id	sid	tid	token	lemma	pos
cord-345304-n74m5ucs	1	1	key	key	NN
cord-345304-n74m5ucs	1	2	:	:	:
cord-345304-n74m5ucs	2	1	cord-345304-n74m5ucs	cord-345304-n74m5ucs	NNP
cord-345304-n74m5ucs	3	1	authors	author	NNS
cord-345304-n74m5ucs	3	2	:	:	:
cord-345304-n74m5ucs	3	3	Safadi	Safadi	NNP
cord-345304-n74m5ucs	3	4	,	,	,
cord-345304-n74m5ucs	3	5	Marco	Marco	NNP
cord-345304-n74m5ucs	3	6	Aurelio	Aurelio	NNP
cord-345304-n74m5ucs	3	7	Palazzi	Palazzi	NNPS
cord-345304-n74m5ucs	3	8	;	;	:
cord-345304-n74m5ucs	3	9	da	da	NNP
cord-345304-n74m5ucs	3	10	Silva	Silva	NNP
cord-345304-n74m5ucs	3	11	,	,	,
cord-345304-n74m5ucs	3	12	Clovis	Clovis	NNP
cord-345304-n74m5ucs	3	13	Artur	Artur	NNP
cord-345304-n74m5ucs	3	14	Almeida	Almeida	NNP
cord-345304-n74m5ucs	3	15	title	title	NN
cord-345304-n74m5ucs	3	16	:	:	:
cord-345304-n74m5ucs	3	17	THE	the	DT
cord-345304-n74m5ucs	3	18	CHALLENGING	challenging	JJ
cord-345304-n74m5ucs	3	19	AND	and	CC
cord-345304-n74m5ucs	3	20	UNPREDICTABLE	unpredictable	JJ
cord-345304-n74m5ucs	3	21	SPECTRUM	spectrum	NN
cord-345304-n74m5ucs	3	22	OF	of	IN
cord-345304-n74m5ucs	3	23	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	3	24	IN	in	IN
cord-345304-n74m5ucs	3	25	CHILDREN	child	NNS
cord-345304-n74m5ucs	3	26	AND	and	CC
cord-345304-n74m5ucs	3	27	ADOLESCENTS	adolescent	NNS
cord-345304-n74m5ucs	3	28	date	date	NN
cord-345304-n74m5ucs	3	29	:	:	:
cord-345304-n74m5ucs	3	30	2020	2020	CD
cord-345304-n74m5ucs	3	31	-	-	HYPH
cord-345304-n74m5ucs	3	32	09	09	CD
cord-345304-n74m5ucs	3	33	-	-	HYPH
cord-345304-n74m5ucs	3	34	07	07	CD
cord-345304-n74m5ucs	3	35	journal	journal	NN
cord-345304-n74m5ucs	3	36	:	:	:
cord-345304-n74m5ucs	4	1	Rev	Rev	NNP
cord-345304-n74m5ucs	4	2	Paul	Paul	NNP
cord-345304-n74m5ucs	4	3	Pediatr	Pediatr	NNP
cord-345304-n74m5ucs	4	4	DOI	DOI	NNP
cord-345304-n74m5ucs	4	5	:	:	:
cord-345304-n74m5ucs	4	6	10.1590/1984	10.1590/1984	CD
cord-345304-n74m5ucs	4	7	-	-	HYPH
cord-345304-n74m5ucs	4	8	0462/2020/38/2020192	0462/2020/38/2020192	CD
cord-345304-n74m5ucs	5	1	sha	sha	NNP
cord-345304-n74m5ucs	5	2	:	:	:
cord-345304-n74m5ucs	6	1	fa6efce980f5389c336d445da1cabd449b1d65b1	fa6efce980f5389c336d445da1cabd449b1d65b1	NNP
cord-345304-n74m5ucs	6	2	doc_id	doc_id	CD
cord-345304-n74m5ucs	6	3	:	:	:
cord-345304-n74m5ucs	6	4	345304	345304	CD
cord-345304-n74m5ucs	6	5	cord_uid	cord_uid	NNS
cord-345304-n74m5ucs	6	6	:	:	:
cord-345304-n74m5ucs	7	1	n74m5ucs	n74m5ucs	NNP
cord-345304-n74m5ucs	8	1	nan	nan	NNP
cord-345304-n74m5ucs	9	1	In	in	IN
cord-345304-n74m5ucs	9	2	the	the	DT
cord-345304-n74m5ucs	9	3	end	end	NN
cord-345304-n74m5ucs	9	4	of	of	IN
cord-345304-n74m5ucs	9	5	Abril	Abril	NNP
cord-345304-n74m5ucs	9	6	,	,	,
cord-345304-n74m5ucs	9	7	cases	case	NNS
cord-345304-n74m5ucs	9	8	of	of	IN
cord-345304-n74m5ucs	9	9	a	a	DT
cord-345304-n74m5ucs	9	10	severe	severe	JJ
cord-345304-n74m5ucs	9	11	rare	rare	JJ
cord-345304-n74m5ucs	9	12	syndrome	syndrome	NN
cord-345304-n74m5ucs	9	13	,	,	,
cord-345304-n74m5ucs	9	14	temporally	temporally	RB
cord-345304-n74m5ucs	9	15	associated	associate	VBN
cord-345304-n74m5ucs	9	16	with	with	IN
cord-345304-n74m5ucs	9	17	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	9	18	,	,	,
cord-345304-n74m5ucs	9	19	have	have	VBP
cord-345304-n74m5ucs	9	20	been	be	VBN
cord-345304-n74m5ucs	9	21	reported	report	VBN
cord-345304-n74m5ucs	9	22	in	in	IN
cord-345304-n74m5ucs	9	23	children	child	NNS
cord-345304-n74m5ucs	9	24	and	and	CC
cord-345304-n74m5ucs	9	25	adolescents	adolescent	NNS
cord-345304-n74m5ucs	9	26	,	,	,
cord-345304-n74m5ucs	9	27	initially	initially	RB
cord-345304-n74m5ucs	9	28	in	in	IN
cord-345304-n74m5ucs	9	29	Europe	Europe	NNP
cord-345304-n74m5ucs	9	30	and	and	CC
cord-345304-n74m5ucs	9	31	then	then	RB
cord-345304-n74m5ucs	9	32	in	in	IN
cord-345304-n74m5ucs	9	33	North	North	NNP
cord-345304-n74m5ucs	9	34	and	and	CC
cord-345304-n74m5ucs	9	35	Latin	Latin	NNP
cord-345304-n74m5ucs	9	36	America	America	NNP
cord-345304-n74m5ucs	9	37	.	.	.
cord-345304-n74m5ucs	10	1	This	this	DT
cord-345304-n74m5ucs	10	2	syndrome	syndrome	NN
cord-345304-n74m5ucs	10	3	,	,	,
cord-345304-n74m5ucs	10	4	named	name	VBN
cord-345304-n74m5ucs	10	5	multisystem	multisystem	JJ
cord-345304-n74m5ucs	10	6	inflammatory	inflammatory	JJ
cord-345304-n74m5ucs	10	7	syndrome	syndrome	NN
cord-345304-n74m5ucs	10	8	in	in	IN
cord-345304-n74m5ucs	10	9	children	child	NNS
cord-345304-n74m5ucs	10	10	(	(	-LRB-
cord-345304-n74m5ucs	10	11	MIS	MIS	NNP
cord-345304-n74m5ucs	10	12	-	-	HYPH
cord-345304-n74m5ucs	10	13	C	C	NNP
cord-345304-n74m5ucs	10	14	)	)	-RRB-
cord-345304-n74m5ucs	10	15	,	,	,
cord-345304-n74m5ucs	10	16	occurs	occur	VBZ
cord-345304-n74m5ucs	10	17	days	day	NNS
cord-345304-n74m5ucs	10	18	to	to	IN
cord-345304-n74m5ucs	10	19	weeks	week	NNS
cord-345304-n74m5ucs	10	20	after	after	IN
cord-345304-n74m5ucs	10	21	acute	acute	JJ
cord-345304-n74m5ucs	10	22	SARS	SARS	NNP
cord-345304-n74m5ucs	10	23	-	-	HYPH
cord-345304-n74m5ucs	10	24	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	10	25	infection	infection	NN
cord-345304-n74m5ucs	10	26	.	.	.
cord-345304-n74m5ucs	11	1	The	the	DT
cord-345304-n74m5ucs	11	2	clinical	clinical	JJ
cord-345304-n74m5ucs	11	3	characteristics	characteristic	NNS
cord-345304-n74m5ucs	11	4	of	of	IN
cord-345304-n74m5ucs	11	5	MIS	MIS	NNP
cord-345304-n74m5ucs	11	6	-	-	HYPH
cord-345304-n74m5ucs	11	7	C	C	NNP
cord-345304-n74m5ucs	11	8	share	share	VBP
cord-345304-n74m5ucs	11	9	similar	similar	JJ
cord-345304-n74m5ucs	11	10	features	feature	NNS
cord-345304-n74m5ucs	11	11	with	with	IN
cord-345304-n74m5ucs	11	12	Kawasaki	Kawasaki	NNP
cord-345304-n74m5ucs	11	13	disease	disease	NN
cord-345304-n74m5ucs	11	14	(	(	-LRB-
cord-345304-n74m5ucs	11	15	KD	KD	NNP
cord-345304-n74m5ucs	11	16	)	)	-RRB-
cord-345304-n74m5ucs	11	17	,	,	,
cord-345304-n74m5ucs	11	18	KD	KD	NNP
cord-345304-n74m5ucs	11	19	shock	shock	NN
cord-345304-n74m5ucs	11	20	syndrome	syndrome	NN
cord-345304-n74m5ucs	11	21	,	,	,
cord-345304-n74m5ucs	11	22	macrophage	macrophage	NN
cord-345304-n74m5ucs	11	23	activation	activation	NN
cord-345304-n74m5ucs	11	24	syndrome	syndrome	NN
cord-345304-n74m5ucs	11	25	(	(	-LRB-
cord-345304-n74m5ucs	11	26	MAS	MAS	NNP
cord-345304-n74m5ucs	11	27	)	)	-RRB-
cord-345304-n74m5ucs	11	28	and	and	CC
cord-345304-n74m5ucs	11	29	toxic	toxic	JJ
cord-345304-n74m5ucs	11	30	shock	shock	NN
cord-345304-n74m5ucs	11	31	syndrome	syndrome	NN
cord-345304-n74m5ucs	11	32	.	.	.
cord-345304-n74m5ucs	12	1	Although	although	IN
cord-345304-n74m5ucs	12	2	many	many	JJ
cord-345304-n74m5ucs	12	3	patients	patient	NNS
cord-345304-n74m5ucs	12	4	with	with	IN
cord-345304-n74m5ucs	12	5	MIS	MIS	NNP
cord-345304-n74m5ucs	12	6	-	-	HYPH
cord-345304-n74m5ucs	12	7	C	C	NNP
cord-345304-n74m5ucs	12	8	meet	meet	VBP
cord-345304-n74m5ucs	12	9	criteria	criterion	NNS
cord-345304-n74m5ucs	12	10	for	for	IN
cord-345304-n74m5ucs	12	11	complete	complete	JJ
cord-345304-n74m5ucs	12	12	or	or	CC
cord-345304-n74m5ucs	12	13	incomplete	incomplete	JJ
cord-345304-n74m5ucs	12	14	KD	KD	NNP
cord-345304-n74m5ucs	12	15	,	,	,
cord-345304-n74m5ucs	12	16	affected	affect	VBN
cord-345304-n74m5ucs	12	17	children	child	NNS
cord-345304-n74m5ucs	12	18	were	be	VBD
cord-345304-n74m5ucs	12	19	older	old	JJR
cord-345304-n74m5ucs	12	20	,	,	,
cord-345304-n74m5ucs	12	21	presented	present	VBD
cord-345304-n74m5ucs	12	22	more	more	RBR
cord-345304-n74m5ucs	12	23	intense	intense	JJ
cord-345304-n74m5ucs	12	24	inflammation	inflammation	NN
cord-345304-n74m5ucs	12	25	and	and	CC
cord-345304-n74m5ucs	12	26	higher	high	JJR
cord-345304-n74m5ucs	12	27	levels	level	NNS
cord-345304-n74m5ucs	12	28	of	of	IN
cord-345304-n74m5ucs	12	29	markers	marker	NNS
cord-345304-n74m5ucs	12	30	of	of	IN
cord-345304-n74m5ucs	12	31	cardiac	cardiac	JJ
cord-345304-n74m5ucs	12	32	injury	injury	NN
cord-345304-n74m5ucs	12	33	.	.	.
cord-345304-n74m5ucs	13	1	A	a	DT
cord-345304-n74m5ucs	13	2	broad	broad	JJ
cord-345304-n74m5ucs	13	3	spectrum	spectrum	NN
cord-345304-n74m5ucs	13	4	of	of	IN
cord-345304-n74m5ucs	13	5	presenting	present	VBG
cord-345304-n74m5ucs	13	6	signs	sign	NNS
cord-345304-n74m5ucs	13	7	and	and	CC
cord-345304-n74m5ucs	13	8	symptoms	symptom	NNS
cord-345304-n74m5ucs	13	9	and	and	CC
cord-345304-n74m5ucs	13	10	disease	disease	NN
cord-345304-n74m5ucs	13	11	severity	severity	NN
cord-345304-n74m5ucs	13	12	were	be	VBD
cord-345304-n74m5ucs	13	13	observed	observe	VBN
cord-345304-n74m5ucs	13	14	among	among	IN
cord-345304-n74m5ucs	13	15	reported	report	VBN
cord-345304-n74m5ucs	13	16	MIS	MIS	NNP
cord-345304-n74m5ucs	13	17	-	-	HYPH
cord-345304-n74m5ucs	13	18	C	C	NNP
cord-345304-n74m5ucs	13	19	cases	case	NNS
cord-345304-n74m5ucs	13	20	,	,	,
cord-345304-n74m5ucs	13	21	including	include	VBG
cord-345304-n74m5ucs	13	22	persistent	persistent	JJ
cord-345304-n74m5ucs	13	23	fever	fever	NN
cord-345304-n74m5ucs	13	24	,	,	,
cord-345304-n74m5ucs	13	25	gastrointestinal	gastrointestinal	JJ
cord-345304-n74m5ucs	13	26	symptoms	symptom	NNS
cord-345304-n74m5ucs	13	27	(	(	-LRB-
cord-345304-n74m5ucs	13	28	abdominal	abdominal	JJ
cord-345304-n74m5ucs	13	29	pain	pain	NN
cord-345304-n74m5ucs	13	30	,	,	,
cord-345304-n74m5ucs	13	31	vomiting	vomiting	NN
cord-345304-n74m5ucs	13	32	,	,	,
cord-345304-n74m5ucs	13	33	diarrhea	diarrhea	NN
cord-345304-n74m5ucs	13	34	)	)	-RRB-
cord-345304-n74m5ucs	13	35	,	,	,
cord-345304-n74m5ucs	13	36	rash	rash	JJ
cord-345304-n74m5ucs	13	37	,	,	,
cord-345304-n74m5ucs	13	38	conjunctivitis	conjunctivitis	NN
cord-345304-n74m5ucs	13	39	,	,	,
cord-345304-n74m5ucs	13	40	progressing	progress	VBG
cord-345304-n74m5ucs	13	41	in	in	IN
cord-345304-n74m5ucs	13	42	some	some	DT
cord-345304-n74m5ucs	13	43	cases	case	NNS
cord-345304-n74m5ucs	13	44	to	to	TO
cord-345304-n74m5ucs	13	45	shock	shock	VB
cord-345304-n74m5ucs	13	46	,	,	,
cord-345304-n74m5ucs	13	47	myocarditis	myocarditis	NN
cord-345304-n74m5ucs	13	48	,	,	,
cord-345304-n74m5ucs	13	49	acute	acute	JJ
cord-345304-n74m5ucs	13	50	heart	heart	NN
cord-345304-n74m5ucs	13	51	failure	failure	NN
cord-345304-n74m5ucs	13	52	and	and	CC
cord-345304-n74m5ucs	13	53	development	development	NN
cord-345304-n74m5ucs	13	54	of	of	IN
cord-345304-n74m5ucs	13	55	coronary	coronary	JJ
cord-345304-n74m5ucs	13	56	artery	artery	NN
cord-345304-n74m5ucs	13	57	aneurysms	aneurysm	NNS
cord-345304-n74m5ucs	13	58	.	.	.
cord-345304-n74m5ucs	14	1	Patients	patient	NNS
cord-345304-n74m5ucs	14	2	who	who	WP
cord-345304-n74m5ucs	14	3	have	have	VBP
cord-345304-n74m5ucs	14	4	presented	present	VBN
cord-345304-n74m5ucs	14	5	with	with	IN
cord-345304-n74m5ucs	14	6	this	this	DT
cord-345304-n74m5ucs	14	7	syndrome	syndrome	NN
cord-345304-n74m5ucs	14	8	were	be	VBD
cord-345304-n74m5ucs	14	9	,	,	,
cord-345304-n74m5ucs	14	10	in	in	IN
cord-345304-n74m5ucs	14	11	general	general	JJ
cord-345304-n74m5ucs	14	12	,	,	,
cord-345304-n74m5ucs	14	13	previously	previously	RB
cord-345304-n74m5ucs	14	14	healthy	healthy	JJ
cord-345304-n74m5ucs	14	15	,	,	,
cord-345304-n74m5ucs	14	16	and	and	CC
cord-345304-n74m5ucs	14	17	most	most	JJS
cord-345304-n74m5ucs	14	18	of	of	IN
cord-345304-n74m5ucs	14	19	them	-PRON-	PRP
cord-345304-n74m5ucs	14	20	have	have	VBP
cord-345304-n74m5ucs	14	21	tested	test	VBN
cord-345304-n74m5ucs	14	22	negative	negative	JJ
cord-345304-n74m5ucs	14	23	for	for	IN
cord-345304-n74m5ucs	14	24	SARS	SARS	NNP
cord-345304-n74m5ucs	14	25	-	-	HYPH
cord-345304-n74m5ucs	14	26	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	14	27	RNA	RNA	NNP
cord-345304-n74m5ucs	14	28	but	but	CC
cord-345304-n74m5ucs	14	29	positive	positive	JJ
cord-345304-n74m5ucs	14	30	for	for	IN
cord-345304-n74m5ucs	14	31	antibodies	antibody	NNS
cord-345304-n74m5ucs	14	32	,	,	,
cord-345304-n74m5ucs	14	33	suggesting	suggest	VBG
cord-345304-n74m5ucs	14	34	an	an	DT
cord-345304-n74m5ucs	14	35	unbalanced	unbalanced	JJ
cord-345304-n74m5ucs	14	36	immune	immune	JJ
cord-345304-n74m5ucs	14	37	response	response	NN
cord-345304-n74m5ucs	14	38	following	follow	VBG
cord-345304-n74m5ucs	14	39	SARS	SARS	NNP
cord-345304-n74m5ucs	14	40	-	-	HYPH
cord-345304-n74m5ucs	14	41	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	14	42	infection	infection	NN
cord-345304-n74m5ucs	14	43	.	.	.
cord-345304-n74m5ucs	15	1	Laboratory	laboratory	NN
cord-345304-n74m5ucs	15	2	findings	finding	NNS
cord-345304-n74m5ucs	15	3	include	include	VBP
cord-345304-n74m5ucs	15	4	lymphocytopenia	lymphocytopenia	NNP
cord-345304-n74m5ucs	15	5	,	,	,
cord-345304-n74m5ucs	15	6	increased	increase	VBN
cord-345304-n74m5ucs	15	7	inflammatory	inflammatory	JJ
cord-345304-n74m5ucs	15	8	(	(	-LRB-
cord-345304-n74m5ucs	15	9	C	c	NN
cord-345304-n74m5ucs	15	10	-	-	HYPH
cord-345304-n74m5ucs	15	11	reactive	reactive	JJ
cord-345304-n74m5ucs	15	12	protein	protein	NN
cord-345304-n74m5ucs	15	13	,	,	,
cord-345304-n74m5ucs	15	14	erythrocyte	erythrocyte	NN
cord-345304-n74m5ucs	15	15	sedimentation	sedimentation	NN
cord-345304-n74m5ucs	15	16	rate	rate	NN
cord-345304-n74m5ucs	15	17	,	,	,
cord-345304-n74m5ucs	15	18	D	d	NN
cord-345304-n74m5ucs	15	19	-	-	HYPH
cord-345304-n74m5ucs	15	20	dimer	dimer	NN
cord-345304-n74m5ucs	15	21	,	,	,
cord-345304-n74m5ucs	15	22	ferritin	ferritin	NN
cord-345304-n74m5ucs	15	23	)	)	-RRB-
cord-345304-n74m5ucs	15	24	and	and	CC
cord-345304-n74m5ucs	15	25	cardiac	cardiac	JJ
cord-345304-n74m5ucs	15	26	biomarkers	biomarker	NNS
cord-345304-n74m5ucs	15	27	(	(	-LRB-
cord-345304-n74m5ucs	15	28	troponin	troponin	JJ
cord-345304-n74m5ucs	15	29	,	,	,
cord-345304-n74m5ucs	15	30	brain	brain	NN
cord-345304-n74m5ucs	15	31	natriuretic	natriuretic	JJ
cord-345304-n74m5ucs	15	32	peptide	peptide	NN
cord-345304-n74m5ucs	15	33	[	[	-LRB-
cord-345304-n74m5ucs	15	34	BNP	BNP	NNP
cord-345304-n74m5ucs	15	35	]	]	-RRB-
cord-345304-n74m5ucs	15	36	)	)	-RRB-
cord-345304-n74m5ucs	15	37	.	.	.
cord-345304-n74m5ucs	16	1	6	6	CD
cord-345304-n74m5ucs	17	1	Based	base	VBN
cord-345304-n74m5ucs	17	2	on	on	IN
cord-345304-n74m5ucs	17	3	current	current	JJ
cord-345304-n74m5ucs	17	4	evidence	evidence	NN
cord-345304-n74m5ucs	17	5	,	,	,
cord-345304-n74m5ucs	17	6	older	old	JJR
cord-345304-n74m5ucs	17	7	adults	adult	NNS
cord-345304-n74m5ucs	17	8	and	and	CC
cord-345304-n74m5ucs	17	9	people	people	NNS
cord-345304-n74m5ucs	17	10	of	of	IN
cord-345304-n74m5ucs	17	11	all	all	DT
cord-345304-n74m5ucs	17	12	ages	age	NNS
cord-345304-n74m5ucs	17	13	with	with	IN
cord-345304-n74m5ucs	17	14	underlying	underlying	JJ
cord-345304-n74m5ucs	17	15	medical	medical	JJ
cord-345304-n74m5ucs	17	16	conditions	condition	NNS
cord-345304-n74m5ucs	17	17	,	,	,
cord-345304-n74m5ucs	17	18	including	include	VBG
cord-345304-n74m5ucs	17	19	severe	severe	JJ
cord-345304-n74m5ucs	17	20	obesity	obesity	NN
cord-345304-n74m5ucs	17	21	,	,	,
cord-345304-n74m5ucs	17	22	chronic	chronic	JJ
cord-345304-n74m5ucs	17	23	lung	lung	NN
cord-345304-n74m5ucs	17	24	disease	disease	NN
cord-345304-n74m5ucs	17	25	,	,	,
cord-345304-n74m5ucs	17	26	cardiovascular	cardiovascular	JJ
cord-345304-n74m5ucs	17	27	disease	disease	NN
cord-345304-n74m5ucs	17	28	,	,	,
cord-345304-n74m5ucs	17	29	diabetes	diabetes	NN
cord-345304-n74m5ucs	17	30	mellitus	mellitus	NN
cord-345304-n74m5ucs	17	31	,	,	,
cord-345304-n74m5ucs	17	32	chronic	chronic	JJ
cord-345304-n74m5ucs	17	33	kidney	kidney	NN
cord-345304-n74m5ucs	17	34	disease	disease	NN
cord-345304-n74m5ucs	17	35	,	,	,
cord-345304-n74m5ucs	17	36	liver	liver	NN
cord-345304-n74m5ucs	17	37	disease	disease	NN
cord-345304-n74m5ucs	17	38	,	,	,
cord-345304-n74m5ucs	17	39	active	active	JJ
cord-345304-n74m5ucs	17	40	cancer	cancer	NN
cord-345304-n74m5ucs	17	41	,	,	,
cord-345304-n74m5ucs	17	42	transplantation	transplantation	NN
cord-345304-n74m5ucs	17	43	and	and	CC
cord-345304-n74m5ucs	17	44	immunocompromised	immunocompromised	JJ
cord-345304-n74m5ucs	17	45	have	have	VBP
cord-345304-n74m5ucs	17	46	been	be	VBN
cord-345304-n74m5ucs	17	47	associated	associate	VBN
cord-345304-n74m5ucs	17	48	with	with	IN
cord-345304-n74m5ucs	17	49	poor	poor	JJ
cord-345304-n74m5ucs	17	50	clinical	clinical	JJ
cord-345304-n74m5ucs	17	51	outcomes	outcome	NNS
cord-345304-n74m5ucs	17	52	and	and	CC
cord-345304-n74m5ucs	17	53	higher	high	JJR
cord-345304-n74m5ucs	17	54	fatality	fatality	NN
cord-345304-n74m5ucs	17	55	rates	rate	NNS
cord-345304-n74m5ucs	17	56	from	from	IN
cord-345304-n74m5ucs	17	57	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	17	58	.	.	NNP
cord-345304-n74m5ucs	17	59	1	1	CD
cord-345304-n74m5ucs	17	60	,	,	,
cord-345304-n74m5ucs	17	61	3	3	CD
cord-345304-n74m5ucs	17	62	There	there	EX
cord-345304-n74m5ucs	17	63	are	be	VBP
cord-345304-n74m5ucs	17	64	limited	limited	JJ
cord-345304-n74m5ucs	17	65	data	datum	NNS
cord-345304-n74m5ucs	17	66	on	on	IN
cord-345304-n74m5ucs	17	67	which	which	WDT
cord-345304-n74m5ucs	17	68	underlying	underlie	VBG
cord-345304-n74m5ucs	17	69	conditions	condition	NNS
cord-345304-n74m5ucs	17	70	in	in	IN
cord-345304-n74m5ucs	17	71	children	child	NNS
cord-345304-n74m5ucs	17	72	and	and	CC
cord-345304-n74m5ucs	17	73	adolescents	adolescent	NNS
cord-345304-n74m5ucs	17	74	are	be	VBP
cord-345304-n74m5ucs	17	75	associated	associate	VBN
cord-345304-n74m5ucs	17	76	with	with	IN
cord-345304-n74m5ucs	17	77	increased	increase	VBN
cord-345304-n74m5ucs	17	78	risk	risk	NN
cord-345304-n74m5ucs	17	79	of	of	IN
cord-345304-n74m5ucs	17	80	infection	infection	NN
cord-345304-n74m5ucs	17	81	or	or	CC
cord-345304-n74m5ucs	17	82	severe	severe	JJ
cord-345304-n74m5ucs	17	83	illness	illness	NN
cord-345304-n74m5ucs	17	84	.	.	.
cord-345304-n74m5ucs	18	1	Infants	infant	NNS
cord-345304-n74m5ucs	18	2	<	<	XX
cord-345304-n74m5ucs	18	3	1	1	CD
cord-345304-n74m5ucs	18	4	year	year	NN
cord-345304-n74m5ucs	18	5	of	of	IN
cord-345304-n74m5ucs	18	6	age	age	NN
cord-345304-n74m5ucs	18	7	and	and	CC
cord-345304-n74m5ucs	18	8	children	child	NNS
cord-345304-n74m5ucs	18	9	with	with	IN
cord-345304-n74m5ucs	18	10	chronic	chronic	JJ
cord-345304-n74m5ucs	18	11	pulmonary	pulmonary	JJ
cord-345304-n74m5ucs	18	12	diseases	disease	NNS
cord-345304-n74m5ucs	18	13	(	(	-LRB-
cord-345304-n74m5ucs	18	14	including	include	VBG
cord-345304-n74m5ucs	18	15	moderate	moderate	JJ
cord-345304-n74m5ucs	18	16	to	to	IN
cord-345304-n74m5ucs	18	17	severe	severe	JJ
cord-345304-n74m5ucs	18	18	asthma	asthma	NN
cord-345304-n74m5ucs	18	19	)	)	-RRB-
cord-345304-n74m5ucs	18	20	,	,	,
cord-345304-n74m5ucs	18	21	cardiovascular	cardiovascular	JJ
cord-345304-n74m5ucs	18	22	illnesses	illness	NNS
cord-345304-n74m5ucs	18	23	(	(	-LRB-
cord-345304-n74m5ucs	18	24	including	include	VBG
cord-345304-n74m5ucs	18	25	congenital	congenital	JJ
cord-345304-n74m5ucs	18	26	heart	heart	NN
cord-345304-n74m5ucs	18	27	disease	disease	NN
cord-345304-n74m5ucs	18	28	)	)	-RRB-
cord-345304-n74m5ucs	18	29	,	,	,
cord-345304-n74m5ucs	18	30	malignancy	malignancy	NN
cord-345304-n74m5ucs	18	31	,	,	,
cord-345304-n74m5ucs	18	32	immunosuppression	immunosuppression	NN
cord-345304-n74m5ucs	18	33	and	and	CC
cord-345304-n74m5ucs	18	34	obesity	obesity	NN
cord-345304-n74m5ucs	18	35	appear	appear	VBP
cord-345304-n74m5ucs	18	36	to	to	TO
cord-345304-n74m5ucs	18	37	be	be	VB
cord-345304-n74m5ucs	18	38	at	at	IN
cord-345304-n74m5ucs	18	39	increased	increase	VBN
cord-345304-n74m5ucs	18	40	risk	risk	NN
cord-345304-n74m5ucs	18	41	of	of	IN
cord-345304-n74m5ucs	18	42	severe	severe	JJ
cord-345304-n74m5ucs	18	43	disease	disease	NN
cord-345304-n74m5ucs	18	44	.	.	.
cord-345304-n74m5ucs	19	1	[	[	-LRB-
cord-345304-n74m5ucs	19	2	8	8	CD
cord-345304-n74m5ucs	19	3	]	]	-RRB-
cord-345304-n74m5ucs	19	4	[	[	-LRB-
cord-345304-n74m5ucs	19	5	9	9	CD
cord-345304-n74m5ucs	19	6	]	]	-RRB-
cord-345304-n74m5ucs	19	7	[	[	-LRB-
cord-345304-n74m5ucs	19	8	10	10	CD
cord-345304-n74m5ucs	19	9	]	]	-RRB-
cord-345304-n74m5ucs	19	10	Data	datum	NNS
cord-345304-n74m5ucs	19	11	of	of	IN
cord-345304-n74m5ucs	19	12	immunocompromised	immunocompromised	JJ
cord-345304-n74m5ucs	19	13	patients	patient	NNS
cord-345304-n74m5ucs	19	14	with	with	IN
cord-345304-n74m5ucs	19	15	autoimmune	autoimmune	JJ
cord-345304-n74m5ucs	19	16	diseases	disease	NNS
cord-345304-n74m5ucs	19	17	and	and	CC
cord-345304-n74m5ucs	19	18	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	19	19	are	be	VBP
cord-345304-n74m5ucs	19	20	scarce	scarce	JJ
cord-345304-n74m5ucs	19	21	.	.	.
cord-345304-n74m5ucs	20	1	Although	although	IN
cord-345304-n74m5ucs	20	2	the	the	DT
cord-345304-n74m5ucs	20	3	true	true	JJ
cord-345304-n74m5ucs	20	4	risk	risk	NN
cord-345304-n74m5ucs	20	5	of	of	IN
cord-345304-n74m5ucs	20	6	life	life	NN
cord-345304-n74m5ucs	20	7	-	-	HYPH
cord-345304-n74m5ucs	20	8	threatening	threaten	VBG
cord-345304-n74m5ucs	20	9	complications	complication	NNS
cord-345304-n74m5ucs	20	10	of	of	IN
cord-345304-n74m5ucs	20	11	this	this	DT
cord-345304-n74m5ucs	20	12	emerging	emerge	VBG
cord-345304-n74m5ucs	20	13	infectious	infectious	JJ
cord-345304-n74m5ucs	20	14	disease	disease	NN
cord-345304-n74m5ucs	20	15	for	for	IN
cord-345304-n74m5ucs	20	16	these	these	DT
cord-345304-n74m5ucs	20	17	chronic	chronic	JJ
cord-345304-n74m5ucs	20	18	illnesses	illness	NNS
cord-345304-n74m5ucs	20	19	is	be	VBZ
cord-345304-n74m5ucs	20	20	not	not	RB
cord-345304-n74m5ucs	20	21	yet	yet	RB
cord-345304-n74m5ucs	20	22	known	know	VBN
cord-345304-n74m5ucs	20	23	,	,	,
cord-345304-n74m5ucs	20	24	there	there	EX
cord-345304-n74m5ucs	20	25	are	be	VBP
cord-345304-n74m5ucs	20	26	particular	particular	JJ
cord-345304-n74m5ucs	20	27	concerns	concern	NNS
cord-345304-n74m5ucs	20	28	regarding	regard	VBG
cord-345304-n74m5ucs	20	29	SARS	SARS	NNP
cord-345304-n74m5ucs	20	30	-	-	HYPH
cord-345304-n74m5ucs	20	31	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	20	32	infection	infection	NN
cord-345304-n74m5ucs	20	33	for	for	IN
cord-345304-n74m5ucs	20	34	patients	patient	NNS
cord-345304-n74m5ucs	20	35	treated	treat	VBN
cord-345304-n74m5ucs	20	36	with	with	IN
cord-345304-n74m5ucs	20	37	immunosuppressive	immunosuppressive	JJ
cord-345304-n74m5ucs	20	38	,	,	,
cord-345304-n74m5ucs	20	39	biological	biological	JJ
cord-345304-n74m5ucs	20	40	agents	agent	NNS
cord-345304-n74m5ucs	20	41	and	and	CC
cord-345304-n74m5ucs	20	42	disease	disease	NN
cord-345304-n74m5ucs	20	43	-	-	HYPH
cord-345304-n74m5ucs	20	44	modifying	modify	VBG
cord-345304-n74m5ucs	20	45	antirheumatic	antirheumatic	JJ
cord-345304-n74m5ucs	20	46	drugs	drug	NNS
cord-345304-n74m5ucs	20	47	.	.	.
cord-345304-n74m5ucs	21	1	11	11	CD
cord-345304-n74m5ucs	21	2	One	one	CD
cord-345304-n74m5ucs	21	3	of	of	IN
cord-345304-n74m5ucs	21	4	the	the	DT
cord-345304-n74m5ucs	21	5	most	most	RBS
cord-345304-n74m5ucs	21	6	important	important	JJ
cord-345304-n74m5ucs	21	7	Latin	latin	JJ
cord-345304-n74m5ucs	21	8	American	american	JJ
cord-345304-n74m5ucs	21	9	reference	reference	NN
cord-345304-n74m5ucs	21	10	centers	center	NNS
cord-345304-n74m5ucs	21	11	for	for	IN
cord-345304-n74m5ucs	21	12	pediatric	pediatric	JJ
cord-345304-n74m5ucs	21	13	liver	liver	NN
cord-345304-n74m5ucs	21	14	diseases	disease	NNS
cord-345304-n74m5ucs	21	15	and	and	CC
cord-345304-n74m5ucs	21	16	pediatric	pediatric	JJ
cord-345304-n74m5ucs	21	17	liver	liver	NN
cord-345304-n74m5ucs	21	18	transplantation	transplantation	NN
cord-345304-n74m5ucs	21	19	in	in	IN
cord-345304-n74m5ucs	21	20	Brazil	Brazil	NNP
cord-345304-n74m5ucs	21	21	described	describe	VBD
cord-345304-n74m5ucs	21	22	their	-PRON-	PRP$
cord-345304-n74m5ucs	21	23	experience	experience	NN
cord-345304-n74m5ucs	21	24	with	with	IN
cord-345304-n74m5ucs	21	25	169	169	CD
cord-345304-n74m5ucs	21	26	non	non	JJ
cord-345304-n74m5ucs	21	27	-	-	JJ
cord-345304-n74m5ucs	21	28	transplant	transplant	JJ
cord-345304-n74m5ucs	21	29	children	child	NNS
cord-345304-n74m5ucs	21	30	and	and	CC
cord-345304-n74m5ucs	21	31	adolescents	adolescent	NNS
cord-345304-n74m5ucs	21	32	suspected	suspect	VBN
cord-345304-n74m5ucs	21	33	and	and	CC
cord-345304-n74m5ucs	21	34	tested	test	VBN
cord-345304-n74m5ucs	21	35	for	for	IN
cord-345304-n74m5ucs	21	36	SARS	SARS	NNP
cord-345304-n74m5ucs	21	37	-	-	HYPH
cord-345304-n74m5ucs	21	38	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	21	39	.	.	.
cord-345304-n74m5ucs	22	1	Of	of	IN
cord-345304-n74m5ucs	22	2	note	note	NN
cord-345304-n74m5ucs	22	3	,	,	,
cord-345304-n74m5ucs	22	4	13/169	13/169	CD
cord-345304-n74m5ucs	22	5	(	(	-LRB-
cord-345304-n74m5ucs	22	6	8	8	CD
cord-345304-n74m5ucs	22	7	%	%	NN
cord-345304-n74m5ucs	22	8	)	)	-RRB-
cord-345304-n74m5ucs	22	9	of	of	IN
cord-345304-n74m5ucs	22	10	them	-PRON-	PRP
cord-345304-n74m5ucs	22	11	had	have	VBD
cord-345304-n74m5ucs	22	12	laboratory	laboratory	NN
cord-345304-n74m5ucs	22	13	-	-	HYPH
cord-345304-n74m5ucs	22	14	confirmed	confirm	VBN
cord-345304-n74m5ucs	22	15	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	22	16	.	.	.
cord-345304-n74m5ucs	23	1	All	all	DT
cord-345304-n74m5ucs	23	2	of	of	IN
cord-345304-n74m5ucs	23	3	them	-PRON-	PRP
cord-345304-n74m5ucs	23	4	had	have	VBD
cord-345304-n74m5ucs	23	5	mild	mild	JJ
cord-345304-n74m5ucs	23	6	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	23	7	,	,	,
cord-345304-n74m5ucs	23	8	except	except	IN
cord-345304-n74m5ucs	23	9	one	one	CD
cord-345304-n74m5ucs	23	10	that	that	WDT
cord-345304-n74m5ucs	23	11	died	die	VBD
cord-345304-n74m5ucs	23	12	due	due	JJ
cord-345304-n74m5ucs	23	13	to	to	IN
cord-345304-n74m5ucs	23	14	a	a	DT
cord-345304-n74m5ucs	23	15	serious	serious	JJ
cord-345304-n74m5ucs	23	16	genetic	genetic	JJ
cord-345304-n74m5ucs	23	17	syndrome	syndrome	NN
cord-345304-n74m5ucs	23	18	.	.	.
cord-345304-n74m5ucs	24	1	Furthermore	furthermore	RB
cord-345304-n74m5ucs	24	2	,	,	,
cord-345304-n74m5ucs	24	3	during	during	IN
cord-345304-n74m5ucs	24	4	the	the	DT
cord-345304-n74m5ucs	24	5	study	study	NN
cord-345304-n74m5ucs	24	6	period	period	NN
cord-345304-n74m5ucs	24	7	,	,	,
cord-345304-n74m5ucs	24	8	none	none	NN
cord-345304-n74m5ucs	24	9	of	of	IN
cord-345304-n74m5ucs	24	10	190	190	CD
cord-345304-n74m5ucs	24	11	pediatric	pediatric	JJ
cord-345304-n74m5ucs	24	12	liver	liver	NN
cord-345304-n74m5ucs	24	13	transplant	transplant	NN
cord-345304-n74m5ucs	24	14	patients	patient	NNS
cord-345304-n74m5ucs	24	15	had	have	VBD
cord-345304-n74m5ucs	24	16	COVID-19	COVID-19	VBN
cord-345304-n74m5ucs	24	17	.	.	.
cord-345304-n74m5ucs	24	18	12	12	CD
cord-345304-n74m5ucs	24	19	Overall	overall	JJ
cord-345304-n74m5ucs	24	20	morbidity	morbidity	NN
cord-345304-n74m5ucs	24	21	and	and	CC
cord-345304-n74m5ucs	24	22	mortality	mortality	NN
cord-345304-n74m5ucs	24	23	of	of	IN
cord-345304-n74m5ucs	24	24	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	24	25	in	in	IN
cord-345304-n74m5ucs	24	26	pediatric	pediatric	JJ
cord-345304-n74m5ucs	24	27	patients	patient	NNS
cord-345304-n74m5ucs	24	28	with	with	IN
cord-345304-n74m5ucs	24	29	cancer	cancer	NN
cord-345304-n74m5ucs	24	30	seem	seem	VBP
cord-345304-n74m5ucs	24	31	to	to	TO
cord-345304-n74m5ucs	24	32	be	be	VB
cord-345304-n74m5ucs	24	33	low	low	JJ
cord-345304-n74m5ucs	24	34	.	.	.
cord-345304-n74m5ucs	25	1	One	one	CD
cord-345304-n74m5ucs	25	2	of	of	IN
cord-345304-n74m5ucs	25	3	the	the	DT
cord-345304-n74m5ucs	25	4	largest	large	JJS
cord-345304-n74m5ucs	25	5	pediatric	pediatric	JJ
cord-345304-n74m5ucs	25	6	cancer	cancer	NN
cord-345304-n74m5ucs	25	7	programs	program	NNS
cord-345304-n74m5ucs	25	8	in	in	IN
cord-345304-n74m5ucs	25	9	the	the	DT
cord-345304-n74m5ucs	25	10	USA	USA	NNP
cord-345304-n74m5ucs	25	11	,	,	,
cord-345304-n74m5ucs	25	12	in	in	IN
cord-345304-n74m5ucs	25	13	New	New	NNP
cord-345304-n74m5ucs	25	14	York	York	NNP
cord-345304-n74m5ucs	25	15	city	city	NN
cord-345304-n74m5ucs	25	16	,	,	,
cord-345304-n74m5ucs	25	17	reported	report	VBD
cord-345304-n74m5ucs	25	18	that	that	IN
cord-345304-n74m5ucs	25	19	20/178	20/178	CD
cord-345304-n74m5ucs	25	20	(	(	-LRB-
cord-345304-n74m5ucs	25	21	11	11	CD
cord-345304-n74m5ucs	25	22	%	%	NN
cord-345304-n74m5ucs	25	23	)	)	-RRB-
cord-345304-n74m5ucs	25	24	children	child	NNS
cord-345304-n74m5ucs	25	25	and	and	CC
cord-345304-n74m5ucs	25	26	adolescents	adolescent	NNS
cord-345304-n74m5ucs	25	27	with	with	IN
cord-345304-n74m5ucs	25	28	cancer	cancer	NN
cord-345304-n74m5ucs	25	29	had	have	VBD
cord-345304-n74m5ucs	25	30	positive	positive	JJ
cord-345304-n74m5ucs	25	31	test	test	NN
cord-345304-n74m5ucs	25	32	for	for	IN
cord-345304-n74m5ucs	25	33	SARS	SARS	NNP
cord-345304-n74m5ucs	25	34	-	-	HYPH
cord-345304-n74m5ucs	25	35	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	25	36	.	.	.
cord-345304-n74m5ucs	26	1	Only	only	RB
cord-345304-n74m5ucs	26	2	one	one	CD
cord-345304-n74m5ucs	26	3	patient	patient	NN
cord-345304-n74m5ucs	26	4	with	with	IN
cord-345304-n74m5ucs	26	5	COVID-19	covid-19	CC
cord-345304-n74m5ucs	26	6	required	require	VBN
cord-345304-n74m5ucs	26	7	noncritical	noncritical	JJ
cord-345304-n74m5ucs	26	8	hospitalization	hospitalization	NN
cord-345304-n74m5ucs	26	9	.	.	.
cord-345304-n74m5ucs	27	1	13	13	CD
cord-345304-n74m5ucs	27	2	Malignancy	malignancy	NN
cord-345304-n74m5ucs	27	3	in	in	IN
cord-345304-n74m5ucs	27	4	pediatric	pediatric	JJ
cord-345304-n74m5ucs	27	5	populations	population	NNS
cord-345304-n74m5ucs	27	6	are	be	VBP
cord-345304-n74m5ucs	27	7	generally	generally	RB
cord-345304-n74m5ucs	27	8	aggressive	aggressive	JJ
cord-345304-n74m5ucs	27	9	,	,	,
cord-345304-n74m5ucs	27	10	needing	need	VBG
cord-345304-n74m5ucs	27	11	multiple	multiple	JJ
cord-345304-n74m5ucs	27	12	chemotherapy	chemotherapy	NN
cord-345304-n74m5ucs	27	13	or	or	CC
cord-345304-n74m5ucs	27	14	stem	stem	NN
cord-345304-n74m5ucs	27	15	cell	cell	NN
cord-345304-n74m5ucs	27	16	transplantation	transplantation	NN
cord-345304-n74m5ucs	27	17	.	.	.
cord-345304-n74m5ucs	28	1	Therefore	therefore	RB
cord-345304-n74m5ucs	28	2	,	,	,
cord-345304-n74m5ucs	28	3	postponing	postpone	VBG
cord-345304-n74m5ucs	28	4	these	these	DT
cord-345304-n74m5ucs	28	5	therapies	therapy	NNS
cord-345304-n74m5ucs	28	6	are	be	VBP
cord-345304-n74m5ucs	28	7	not	not	RB
cord-345304-n74m5ucs	28	8	recommended	recommend	VBN
cord-345304-n74m5ucs	28	9	during	during	IN
cord-345304-n74m5ucs	28	10	COVID-19	covid-19	JJ
cord-345304-n74m5ucs	28	11	pandemic	pandemic	NN
cord-345304-n74m5ucs	28	12	.	.	.
cord-345304-n74m5ucs	29	1	Importantly	importantly	RB
cord-345304-n74m5ucs	29	2	,	,	,
cord-345304-n74m5ucs	29	3	the	the	DT
cord-345304-n74m5ucs	29	4	long	long	JJ
cord-345304-n74m5ucs	29	5	-	-	HYPH
cord-345304-n74m5ucs	29	6	term	term	NN
cord-345304-n74m5ucs	29	7	effects	effect	NNS
cord-345304-n74m5ucs	29	8	of	of	IN
cord-345304-n74m5ucs	29	9	this	this	DT
cord-345304-n74m5ucs	29	10	pandemic	pandemic	NN
cord-345304-n74m5ucs	29	11	,	,	,
cord-345304-n74m5ucs	29	12	with	with	IN
cord-345304-n74m5ucs	29	13	school	school	NN
cord-345304-n74m5ucs	29	14	closure	closure	NN
cord-345304-n74m5ucs	29	15	and	and	CC
cord-345304-n74m5ucs	29	16	social	social	JJ
cord-345304-n74m5ucs	29	17	isolation	isolation	NN
cord-345304-n74m5ucs	29	18	during	during	IN
cord-345304-n74m5ucs	29	19	quarantine	quarantine	NN
cord-345304-n74m5ucs	29	20	/	/	SYM
cord-345304-n74m5ucs	29	21	lockdown	lockdown	NN
cord-345304-n74m5ucs	29	22	for	for	IN
cord-345304-n74m5ucs	29	23	children	child	NNS
cord-345304-n74m5ucs	29	24	and	and	CC
cord-345304-n74m5ucs	29	25	adolescents	adolescent	NNS
cord-345304-n74m5ucs	29	26	,	,	,
cord-345304-n74m5ucs	29	27	may	may	MD
cord-345304-n74m5ucs	29	28	influence	influence	VB
cord-345304-n74m5ucs	29	29	sedentary	sedentary	JJ
cord-345304-n74m5ucs	29	30	behavior	behavior	NN
cord-345304-n74m5ucs	29	31	and	and	CC
cord-345304-n74m5ucs	29	32	consumption	consumption	NN
cord-345304-n74m5ucs	29	33	of	of	IN
cord-345304-n74m5ucs	29	34	calories	calorie	NNS
cord-345304-n74m5ucs	29	35	-	-	HYPH
cord-345304-n74m5ucs	29	36	dense	dense	JJ
cord-345304-n74m5ucs	29	37	comfort	comfort	NN
cord-345304-n74m5ucs	29	38	foods	food	NNS
cord-345304-n74m5ucs	29	39	,	,	,
cord-345304-n74m5ucs	29	40	increasing	increase	VBG
cord-345304-n74m5ucs	29	41	the	the	DT
cord-345304-n74m5ucs	29	42	risk	risk	NN
cord-345304-n74m5ucs	29	43	of	of	IN
cord-345304-n74m5ucs	29	44	weight	weight	NN
cord-345304-n74m5ucs	29	45	gain	gain	NN
cord-345304-n74m5ucs	29	46	and	and	CC
cord-345304-n74m5ucs	29	47	contributing	contribute	VBG
cord-345304-n74m5ucs	29	48	for	for	IN
cord-345304-n74m5ucs	29	49	metabolic	metabolic	JJ
cord-345304-n74m5ucs	29	50	and	and	CC
cord-345304-n74m5ucs	29	51	cardiovascular	cardiovascular	JJ
cord-345304-n74m5ucs	29	52	diseases	disease	NNS
cord-345304-n74m5ucs	29	53	,	,	,
cord-345304-n74m5ucs	29	54	particularly	particularly	RB
cord-345304-n74m5ucs	29	55	among	among	IN
cord-345304-n74m5ucs	29	56	those	those	DT
cord-345304-n74m5ucs	29	57	living	live	VBG
cord-345304-n74m5ucs	29	58	in	in	IN
cord-345304-n74m5ucs	29	59	urban	urban	JJ
cord-345304-n74m5ucs	29	60	districts	district	NNS
cord-345304-n74m5ucs	29	61	.	.	.
cord-345304-n74m5ucs	30	1	11	11	LS
cord-345304-n74m5ucs	30	2	There	there	EX
cord-345304-n74m5ucs	30	3	are	be	VBP
cord-345304-n74m5ucs	30	4	other	other	JJ
cord-345304-n74m5ucs	30	5	challenges	challenge	NNS
cord-345304-n74m5ucs	30	6	related	relate	VBN
cord-345304-n74m5ucs	30	7	to	to	IN
cord-345304-n74m5ucs	30	8	this	this	DT
cord-345304-n74m5ucs	30	9	pandemic	pandemic	NN
cord-345304-n74m5ucs	30	10	in	in	IN
cord-345304-n74m5ucs	30	11	children	child	NNS
cord-345304-n74m5ucs	30	12	and	and	CC
cord-345304-n74m5ucs	30	13	adolescents	adolescent	NNS
cord-345304-n74m5ucs	30	14	.	.	.
cord-345304-n74m5ucs	31	1	Non	non	JJ
cord-345304-n74m5ucs	31	2	-	-	JJ
cord-345304-n74m5ucs	31	3	pharmacological	pharmacological	JJ
cord-345304-n74m5ucs	31	4	interventions	intervention	NNS
cord-345304-n74m5ucs	31	5	have	have	VBP
cord-345304-n74m5ucs	31	6	been	be	VBN
cord-345304-n74m5ucs	31	7	an	an	DT
cord-345304-n74m5ucs	31	8	essential	essential	JJ
cord-345304-n74m5ucs	31	9	preventive	preventive	JJ
cord-345304-n74m5ucs	31	10	measure	measure	NN
cord-345304-n74m5ucs	31	11	,	,	,
cord-345304-n74m5ucs	31	12	recommended	recommend	VBN
cord-345304-n74m5ucs	31	13	by	by	IN
cord-345304-n74m5ucs	31	14	national	national	JJ
cord-345304-n74m5ucs	31	15	and	and	CC
cord-345304-n74m5ucs	31	16	international	international	JJ
cord-345304-n74m5ucs	31	17	public	public	JJ
cord-345304-n74m5ucs	31	18	health	health	NN
cord-345304-n74m5ucs	31	19	authorities	authority	NNS
cord-345304-n74m5ucs	31	20	.	.	.
cord-345304-n74m5ucs	32	1	Besides	besides	IN
cord-345304-n74m5ucs	32	2	the	the	DT
cord-345304-n74m5ucs	32	3	risk	risk	NN
cord-345304-n74m5ucs	32	4	of	of	IN
cord-345304-n74m5ucs	32	5	limited	limited	JJ
cord-345304-n74m5ucs	32	6	or	or	CC
cord-345304-n74m5ucs	32	7	even	even	RB
cord-345304-n74m5ucs	32	8	no	no	DT
cord-345304-n74m5ucs	32	9	education	education	NN
cord-345304-n74m5ucs	32	10	for	for	IN
cord-345304-n74m5ucs	32	11	children	child	NNS
cord-345304-n74m5ucs	32	12	and	and	CC
cord-345304-n74m5ucs	32	13	adolescents	adolescent	NNS
cord-345304-n74m5ucs	32	14	during	during	IN
cord-345304-n74m5ucs	32	15	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	32	16	crisis	crisis	NN
cord-345304-n74m5ucs	32	17	,	,	,
cord-345304-n74m5ucs	32	18	home	home	NN
cord-345304-n74m5ucs	32	19	confinements	confinement	NNS
cord-345304-n74m5ucs	32	20	may	may	MD
cord-345304-n74m5ucs	32	21	induce	induce	VB
cord-345304-n74m5ucs	32	22	longer	long	JJR
cord-345304-n74m5ucs	32	23	screen	screen	NN
cord-345304-n74m5ucs	32	24	time	time	NN
cord-345304-n74m5ucs	32	25	,	,	,
cord-345304-n74m5ucs	32	26	physical	physical	JJ
cord-345304-n74m5ucs	32	27	inactivity	inactivity	NN
cord-345304-n74m5ucs	32	28	,	,	,
cord-345304-n74m5ucs	32	29	sleep	sleep	NN
cord-345304-n74m5ucs	32	30	abnormalities	abnormality	NNS
cord-345304-n74m5ucs	32	31	,	,	,
cord-345304-n74m5ucs	32	32	increase	increase	VBP
cord-345304-n74m5ucs	32	33	alcohol	alcohol	NN
cord-345304-n74m5ucs	32	34	intake	intake	NN
cord-345304-n74m5ucs	32	35	risk	risk	NN
cord-345304-n74m5ucs	32	36	and	and	CC
cord-345304-n74m5ucs	32	37	domestic	domestic	JJ
cord-345304-n74m5ucs	32	38	violence	violence	NN
cord-345304-n74m5ucs	32	39	,	,	,
cord-345304-n74m5ucs	32	40	particularly	particularly	RB
cord-345304-n74m5ucs	32	41	in	in	IN
cord-345304-n74m5ucs	32	42	adolescents	adolescent	NNS
cord-345304-n74m5ucs	32	43	.	.	.
cord-345304-n74m5ucs	33	1	Drug	drug	NN
cord-345304-n74m5ucs	33	2	adherence	adherence	NN
cord-345304-n74m5ucs	33	3	should	should	MD
cord-345304-n74m5ucs	33	4	also	also	RB
cord-345304-n74m5ucs	33	5	be	be	VB
cord-345304-n74m5ucs	33	6	reinforced	reinforce	VBN
cord-345304-n74m5ucs	33	7	for	for	IN
cord-345304-n74m5ucs	33	8	patients	patient	NNS
cord-345304-n74m5ucs	33	9	with	with	IN
cord-345304-n74m5ucs	33	10	preexisting	preexist	VBG
cord-345304-n74m5ucs	33	11	chronic	chronic	JJ
cord-345304-n74m5ucs	33	12	disease	disease	NN
cord-345304-n74m5ucs	33	13	and	and	CC
cord-345304-n74m5ucs	33	14	their	-PRON-	PRP$
cord-345304-n74m5ucs	33	15	families	family	NNS
cord-345304-n74m5ucs	33	16	due	due	JJ
cord-345304-n74m5ucs	33	17	to	to	IN
cord-345304-n74m5ucs	33	18	risk	risk	NN
cord-345304-n74m5ucs	33	19	of	of	IN
cord-345304-n74m5ucs	33	20	disease	disease	NN
cord-345304-n74m5ucs	33	21	flare	flare	NN
cord-345304-n74m5ucs	33	22	or	or	CC
cord-345304-n74m5ucs	33	23	disease	disease	NN
cord-345304-n74m5ucs	33	24	damage	damage	NN
cord-345304-n74m5ucs	33	25	.	.	.
cord-345304-n74m5ucs	34	1	Patients	patient	NNS
cord-345304-n74m5ucs	34	2	with	with	IN
cord-345304-n74m5ucs	34	3	suspected	suspect	VBN
cord-345304-n74m5ucs	34	4	or	or	CC
cord-345304-n74m5ucs	34	5	confirmed	confirm	VBN
cord-345304-n74m5ucs	34	6	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	34	7	must	must	MD
cord-345304-n74m5ucs	34	8	be	be	VB
cord-345304-n74m5ucs	34	9	strictly	strictly	RB
cord-345304-n74m5ucs	34	10	monitored	monitor	VBN
cord-345304-n74m5ucs	34	11	for	for	IN
cord-345304-n74m5ucs	34	12	the	the	DT
cord-345304-n74m5ucs	34	13	possible	possible	JJ
cord-345304-n74m5ucs	34	14	risk	risk	NN
cord-345304-n74m5ucs	34	15	of	of	IN
cord-345304-n74m5ucs	34	16	disease	disease	NN
cord-345304-n74m5ucs	34	17	reactivation	reactivation	NN
cord-345304-n74m5ucs	34	18	after	after	IN
cord-345304-n74m5ucs	34	19	the	the	DT
cord-345304-n74m5ucs	34	20	resolution	resolution	NN
cord-345304-n74m5ucs	34	21	of	of	IN
cord-345304-n74m5ucs	34	22	this	this	DT
cord-345304-n74m5ucs	34	23	viral	viral	JJ
cord-345304-n74m5ucs	34	24	infection	infection	NN
cord-345304-n74m5ucs	34	25	.	.	.
cord-345304-n74m5ucs	35	1	11	11	CD
cord-345304-n74m5ucs	36	1	The	the	DT
cord-345304-n74m5ucs	36	2	overwhelmed	overwhelmed	JJ
cord-345304-n74m5ucs	36	3	public	public	JJ
cord-345304-n74m5ucs	36	4	health	health	NN
cord-345304-n74m5ucs	36	5	systems	system	NNS
cord-345304-n74m5ucs	36	6	by	by	IN
cord-345304-n74m5ucs	36	7	the	the	DT
cord-345304-n74m5ucs	36	8	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	36	9	pandemic	pandemic	NN
cord-345304-n74m5ucs	36	10	represents	represent	VBZ
cord-345304-n74m5ucs	36	11	a	a	DT
cord-345304-n74m5ucs	36	12	serious	serious	JJ
cord-345304-n74m5ucs	36	13	risk	risk	NN
cord-345304-n74m5ucs	36	14	for	for	IN
cord-345304-n74m5ucs	36	15	pediatric	pediatric	JJ
cord-345304-n74m5ucs	36	16	general	general	JJ
cord-345304-n74m5ucs	36	17	health	health	NN
cord-345304-n74m5ucs	36	18	,	,	,
cord-345304-n74m5ucs	36	19	limiting	limit	VBG
cord-345304-n74m5ucs	36	20	access	access	NN
cord-345304-n74m5ucs	36	21	of	of	IN
cord-345304-n74m5ucs	36	22	children	child	NNS
cord-345304-n74m5ucs	36	23	and	and	CC
cord-345304-n74m5ucs	36	24	adolescents	adolescent	NNS
cord-345304-n74m5ucs	36	25	to	to	IN
cord-345304-n74m5ucs	36	26	basic	basic	JJ
cord-345304-n74m5ucs	36	27	health	health	NN
cord-345304-n74m5ucs	36	28	care	care	NN
cord-345304-n74m5ucs	36	29	,	,	,
cord-345304-n74m5ucs	36	30	compromising	compromise	VBG
cord-345304-n74m5ucs	36	31	immunization	immunization	NN
cord-345304-n74m5ucs	36	32	coverages	coverage	NNS
cord-345304-n74m5ucs	36	33	and	and	CC
cord-345304-n74m5ucs	36	34	postponing	postpone	VBG
cord-345304-n74m5ucs	36	35	consultations	consultation	NNS
cord-345304-n74m5ucs	36	36	for	for	IN
cord-345304-n74m5ucs	36	37	patients	patient	NNS
cord-345304-n74m5ucs	36	38	with	with	IN
cord-345304-n74m5ucs	36	39	underlying	underlying	JJ
cord-345304-n74m5ucs	36	40	conditions	condition	NNS
cord-345304-n74m5ucs	36	41	.	.	.
cord-345304-n74m5ucs	37	1	Moreover	moreover	RB
cord-345304-n74m5ucs	37	2	,	,	,
cord-345304-n74m5ucs	37	3	mental	mental	JJ
cord-345304-n74m5ucs	37	4	health	health	NN
cord-345304-n74m5ucs	37	5	burden	burden	NN
cord-345304-n74m5ucs	37	6	and	and	CC
cord-345304-n74m5ucs	37	7	socio	socio	JJ
cord-345304-n74m5ucs	37	8	-	-	HYPH
cord-345304-n74m5ucs	37	9	economic	economic	JJ
cord-345304-n74m5ucs	37	10	issues	issue	NNS
cord-345304-n74m5ucs	37	11	may	may	MD
cord-345304-n74m5ucs	37	12	contribute	contribute	VB
cord-345304-n74m5ucs	37	13	for	for	IN
cord-345304-n74m5ucs	37	14	short	short	JJ
cord-345304-n74m5ucs	37	15	and	and	CC
cord-345304-n74m5ucs	37	16	long	long	JJ
cord-345304-n74m5ucs	37	17	-	-	HYPH
cord-345304-n74m5ucs	37	18	term	term	NN
cord-345304-n74m5ucs	37	19	negative	negative	JJ
cord-345304-n74m5ucs	37	20	outcomes	outcome	NNS
cord-345304-n74m5ucs	37	21	in	in	IN
cord-345304-n74m5ucs	37	22	children	child	NNS
cord-345304-n74m5ucs	37	23	and	and	CC
cord-345304-n74m5ucs	37	24	adolescents	adolescent	NNS
cord-345304-n74m5ucs	37	25	and	and	CC
cord-345304-n74m5ucs	37	26	their	-PRON-	PRP$
cord-345304-n74m5ucs	37	27	families	family	NNS
cord-345304-n74m5ucs	37	28	.	.	.
cord-345304-n74m5ucs	38	1	Acute	acute	JJ
cord-345304-n74m5ucs	38	2	stress	stress	NN
cord-345304-n74m5ucs	38	3	,	,	,
cord-345304-n74m5ucs	38	4	anxiety	anxiety	NN
cord-345304-n74m5ucs	38	5	,	,	,
cord-345304-n74m5ucs	38	6	mild	mild	JJ
cord-345304-n74m5ucs	38	7	to	to	IN
cord-345304-n74m5ucs	38	8	severe	severe	JJ
cord-345304-n74m5ucs	38	9	depression	depression	NN
cord-345304-n74m5ucs	38	10	,	,	,
cord-345304-n74m5ucs	38	11	post	post	JJ
cord-345304-n74m5ucs	38	12	-	-	JJ
cord-345304-n74m5ucs	38	13	traumatic	traumatic	JJ
cord-345304-n74m5ucs	38	14	stress	stress	NN
cord-345304-n74m5ucs	38	15	disorder	disorder	NN
cord-345304-n74m5ucs	38	16	,	,	,
cord-345304-n74m5ucs	38	17	and	and	CC
cord-345304-n74m5ucs	38	18	emotional	emotional	JJ
cord-345304-n74m5ucs	38	19	exhaustion	exhaustion	NN
cord-345304-n74m5ucs	38	20	may	may	MD
cord-345304-n74m5ucs	38	21	be	be	VB
cord-345304-n74m5ucs	38	22	first	first	RB
cord-345304-n74m5ucs	38	23	diagnosed	diagnose	VBN
cord-345304-n74m5ucs	38	24	during	during	IN
cord-345304-n74m5ucs	38	25	or	or	CC
cord-345304-n74m5ucs	38	26	after	after	IN
cord-345304-n74m5ucs	38	27	COVID-19	covid-19	JJ
cord-345304-n74m5ucs	38	28	pandemic	pandemic	NN
cord-345304-n74m5ucs	38	29	.	.	.
cord-345304-n74m5ucs	39	1	Thus	thus	RB
cord-345304-n74m5ucs	39	2	,	,	,
cord-345304-n74m5ucs	39	3	online	online	JJ
cord-345304-n74m5ucs	39	4	mental	mental	JJ
cord-345304-n74m5ucs	39	5	health	health	NN
cord-345304-n74m5ucs	39	6	care	care	NN
cord-345304-n74m5ucs	39	7	delivery	delivery	NN
cord-345304-n74m5ucs	39	8	,	,	,
cord-345304-n74m5ucs	39	9	using	use	VBG
cord-345304-n74m5ucs	39	10	teleconsultation	teleconsultation	NN
cord-345304-n74m5ucs	39	11	or	or	CC
cord-345304-n74m5ucs	39	12	telephone	telephone	NN
cord-345304-n74m5ucs	39	13	support	support	NN
cord-345304-n74m5ucs	39	14	lines	line	NNS
cord-345304-n74m5ucs	39	15	,	,	,
cord-345304-n74m5ucs	39	16	may	may	MD
cord-345304-n74m5ucs	39	17	be	be	VB
cord-345304-n74m5ucs	39	18	required	require	VBN
cord-345304-n74m5ucs	39	19	for	for	IN
cord-345304-n74m5ucs	39	20	pediatric	pediatric	JJ
cord-345304-n74m5ucs	39	21	populations	population	NNS
cord-345304-n74m5ucs	39	22	.	.	.
cord-345304-n74m5ucs	40	1	14	14	CD
cord-345304-n74m5ucs	40	2	Identification	identification	NN
cord-345304-n74m5ucs	40	3	of	of	IN
cord-345304-n74m5ucs	40	4	a	a	DT
cord-345304-n74m5ucs	40	5	safe	safe	JJ
cord-345304-n74m5ucs	40	6	and	and	CC
cord-345304-n74m5ucs	40	7	effective	effective	JJ
cord-345304-n74m5ucs	40	8	antiviral	antiviral	JJ
cord-345304-n74m5ucs	40	9	therapy	therapy	NN
cord-345304-n74m5ucs	40	10	,	,	,
cord-345304-n74m5ucs	40	11	that	that	WDT
cord-345304-n74m5ucs	40	12	could	could	MD
cord-345304-n74m5ucs	40	13	improve	improve	VB
cord-345304-n74m5ucs	40	14	disease	disease	NN
cord-345304-n74m5ucs	40	15	outcomes	outcome	NNS
cord-345304-n74m5ucs	40	16	,	,	,
cord-345304-n74m5ucs	40	17	has	have	VBZ
cord-345304-n74m5ucs	40	18	been	be	VBN
cord-345304-n74m5ucs	40	19	object	object	NN
cord-345304-n74m5ucs	40	20	of	of	IN
cord-345304-n74m5ucs	40	21	extensive	extensive	JJ
cord-345304-n74m5ucs	40	22	research	research	NN
cord-345304-n74m5ucs	40	23	worldwide	worldwide	RB
cord-345304-n74m5ucs	40	24	.	.	.
cord-345304-n74m5ucs	41	1	However	however	RB
cord-345304-n74m5ucs	41	2	,	,	,
cord-345304-n74m5ucs	41	3	so	so	RB
cord-345304-n74m5ucs	41	4	far	far	RB
cord-345304-n74m5ucs	41	5	there	there	EX
cord-345304-n74m5ucs	41	6	are	be	VBP
cord-345304-n74m5ucs	41	7	no	no	DT
cord-345304-n74m5ucs	41	8	convincing	convincing	JJ
cord-345304-n74m5ucs	41	9	data	datum	NNS
cord-345304-n74m5ucs	41	10	showing	show	VBG
cord-345304-n74m5ucs	41	11	that	that	IN
cord-345304-n74m5ucs	41	12	any	any	DT
cord-345304-n74m5ucs	41	13	of	of	IN
cord-345304-n74m5ucs	41	14	the	the	DT
cord-345304-n74m5ucs	41	15	several	several	JJ
cord-345304-n74m5ucs	41	16	antivirals	antiviral	NNS
cord-345304-n74m5ucs	41	17	(	(	-LRB-
cord-345304-n74m5ucs	41	18	protease	protease	NN
cord-345304-n74m5ucs	41	19	inhibitor	inhibitor	NN
cord-345304-n74m5ucs	41	20	lopinavir	lopinavir	NNS
cord-345304-n74m5ucs	41	21	/	/	SYM
cord-345304-n74m5ucs	41	22	ritonavir	ritonavir	NNP
cord-345304-n74m5ucs	41	23	,	,	,
cord-345304-n74m5ucs	41	24	remdesivir	remdesivir	NNP
cord-345304-n74m5ucs	41	25	or	or	CC
cord-345304-n74m5ucs	41	26	favipiravir	favipiravir	NNP
cord-345304-n74m5ucs	41	27	)	)	-RRB-
cord-345304-n74m5ucs	41	28	that	that	WDT
cord-345304-n74m5ucs	41	29	are	be	VBP
cord-345304-n74m5ucs	41	30	being	be	VBG
cord-345304-n74m5ucs	41	31	tested	test	VBN
cord-345304-n74m5ucs	41	32	proved	prove	VBN
cord-345304-n74m5ucs	41	33	to	to	TO
cord-345304-n74m5ucs	41	34	be	be	VB
cord-345304-n74m5ucs	41	35	safe	safe	JJ
cord-345304-n74m5ucs	41	36	and	and	CC
cord-345304-n74m5ucs	41	37	efficacious	efficacious	JJ
cord-345304-n74m5ucs	41	38	against	against	IN
cord-345304-n74m5ucs	41	39	SARS	SARS	NNP
cord-345304-n74m5ucs	41	40	-	-	HYPH
cord-345304-n74m5ucs	41	41	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	41	42	.	.	.
cord-345304-n74m5ucs	42	1	Moreover	moreover	RB
cord-345304-n74m5ucs	42	2	,	,	,
cord-345304-n74m5ucs	42	3	it	-PRON-	PRP
cord-345304-n74m5ucs	42	4	must	must	MD
cord-345304-n74m5ucs	42	5	be	be	VB
cord-345304-n74m5ucs	42	6	acknowledged	acknowledge	VBN
cord-345304-n74m5ucs	42	7	that	that	IN
cord-345304-n74m5ucs	42	8	the	the	DT
cord-345304-n74m5ucs	42	9	majority	majority	NN
cord-345304-n74m5ucs	42	10	of	of	IN
cord-345304-n74m5ucs	42	11	these	these	DT
cord-345304-n74m5ucs	42	12	trials	trial	NNS
cord-345304-n74m5ucs	42	13	have	have	VBP
cord-345304-n74m5ucs	42	14	been	be	VBN
cord-345304-n74m5ucs	42	15	performed	perform	VBN
cord-345304-n74m5ucs	42	16	in	in	IN
cord-345304-n74m5ucs	42	17	adults	adult	NNS
cord-345304-n74m5ucs	42	18	,	,	,
cord-345304-n74m5ucs	42	19	with	with	IN
cord-345304-n74m5ucs	42	20	very	very	RB
cord-345304-n74m5ucs	42	21	limited	limited	JJ
cord-345304-n74m5ucs	42	22	data	datum	NNS
cord-345304-n74m5ucs	42	23	,	,	,
cord-345304-n74m5ucs	42	24	if	if	IN
cord-345304-n74m5ucs	42	25	any	any	DT
cord-345304-n74m5ucs	42	26	,	,	,
cord-345304-n74m5ucs	42	27	for	for	IN
cord-345304-n74m5ucs	42	28	most	most	JJS
cord-345304-n74m5ucs	42	29	of	of	IN
cord-345304-n74m5ucs	42	30	the	the	DT
cord-345304-n74m5ucs	42	31	different	different	JJ
cord-345304-n74m5ucs	42	32	candidate	candidate	NN
cord-345304-n74m5ucs	42	33	antiviral	antiviral	JJ
cord-345304-n74m5ucs	42	34	therapies	therapy	NNS
cord-345304-n74m5ucs	42	35	in	in	IN
cord-345304-n74m5ucs	42	36	children	child	NNS
cord-345304-n74m5ucs	42	37	.	.	.
cord-345304-n74m5ucs	43	1	15	15	CD
cord-345304-n74m5ucs	44	1	It	-PRON-	PRP
cord-345304-n74m5ucs	44	2	is	be	VBZ
cord-345304-n74m5ucs	44	3	also	also	RB
cord-345304-n74m5ucs	44	4	of	of	IN
cord-345304-n74m5ucs	44	5	paramount	paramount	JJ
cord-345304-n74m5ucs	44	6	importance	importance	NN
cord-345304-n74m5ucs	44	7	to	to	TO
cord-345304-n74m5ucs	44	8	have	have	VB
cord-345304-n74m5ucs	44	9	in	in	IN
cord-345304-n74m5ucs	44	10	mind	mind	NN
cord-345304-n74m5ucs	44	11	that	that	IN
cord-345304-n74m5ucs	44	12	the	the	DT
cord-345304-n74m5ucs	44	13	overwhelming	overwhelming	JJ
cord-345304-n74m5ucs	44	14	majority	majority	NN
cord-345304-n74m5ucs	44	15	of	of	IN
cord-345304-n74m5ucs	44	16	children	child	NNS
cord-345304-n74m5ucs	44	17	and	and	CC
cord-345304-n74m5ucs	44	18	adolescents	adolescent	NNS
cord-345304-n74m5ucs	44	19	with	with	IN
cord-345304-n74m5ucs	44	20	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	44	21	,	,	,
cord-345304-n74m5ucs	44	22	once	once	RB
cord-345304-n74m5ucs	44	23	infected	infect	VBN
cord-345304-n74m5ucs	44	24	,	,	,
cord-345304-n74m5ucs	44	25	will	will	MD
cord-345304-n74m5ucs	44	26	develop	develop	VB
cord-345304-n74m5ucs	44	27	a	a	DT
cord-345304-n74m5ucs	44	28	mild	mild	JJ
cord-345304-n74m5ucs	44	29	,	,	,
cord-345304-n74m5ucs	44	30	self	self	NN
cord-345304-n74m5ucs	44	31	-	-	HYPH
cord-345304-n74m5ucs	44	32	limited	limit	VBN
cord-345304-n74m5ucs	44	33	form	form	NN
cord-345304-n74m5ucs	44	34	of	of	IN
cord-345304-n74m5ucs	44	35	disease	disease	NN
cord-345304-n74m5ucs	44	36	.	.	.
cord-345304-n74m5ucs	45	1	It	-PRON-	PRP
cord-345304-n74m5ucs	45	2	means	mean	VBZ
cord-345304-n74m5ucs	45	3	that	that	IN
cord-345304-n74m5ucs	45	4	a	a	DT
cord-345304-n74m5ucs	45	5	large	large	JJ
cord-345304-n74m5ucs	45	6	number	number	NN
cord-345304-n74m5ucs	45	7	of	of	IN
cord-345304-n74m5ucs	45	8	patients	patient	NNS
cord-345304-n74m5ucs	45	9	would	would	MD
cord-345304-n74m5ucs	45	10	have	have	VB
cord-345304-n74m5ucs	45	11	to	to	TO
cord-345304-n74m5ucs	45	12	be	be	VB
cord-345304-n74m5ucs	45	13	treated	treat	VBN
cord-345304-n74m5ucs	45	14	in	in	IN
cord-345304-n74m5ucs	45	15	order	order	NN
cord-345304-n74m5ucs	45	16	to	to	TO
cord-345304-n74m5ucs	45	17	demonstrate	demonstrate	VB
cord-345304-n74m5ucs	45	18	the	the	DT
cord-345304-n74m5ucs	45	19	benefits	benefit	NNS
cord-345304-n74m5ucs	45	20	of	of	IN
cord-345304-n74m5ucs	45	21	an	an	DT
cord-345304-n74m5ucs	45	22	antiviral	antiviral	JJ
cord-345304-n74m5ucs	45	23	,	,	,
cord-345304-n74m5ucs	45	24	raising	raise	VBG
cord-345304-n74m5ucs	45	25	concerns	concern	NNS
cord-345304-n74m5ucs	45	26	of	of	IN
cord-345304-n74m5ucs	45	27	the	the	DT
cord-345304-n74m5ucs	45	28	potential	potential	JJ
cord-345304-n74m5ucs	45	29	adverse	adverse	JJ
cord-345304-n74m5ucs	45	30	events	event	NNS
cord-345304-n74m5ucs	45	31	associated	associate	VBN
cord-345304-n74m5ucs	45	32	with	with	IN
cord-345304-n74m5ucs	45	33	this	this	DT
cord-345304-n74m5ucs	45	34	intervention	intervention	NN
cord-345304-n74m5ucs	45	35	.	.	.
cord-345304-n74m5ucs	46	1	This	this	DT
cord-345304-n74m5ucs	46	2	way	way	NN
cord-345304-n74m5ucs	46	3	,	,	,
cord-345304-n74m5ucs	46	4	it	-PRON-	PRP
cord-345304-n74m5ucs	46	5	is	be	VBZ
cord-345304-n74m5ucs	46	6	our	-PRON-	PRP$
cord-345304-n74m5ucs	46	7	opinion	opinion	NN
cord-345304-n74m5ucs	46	8	that	that	IN
cord-345304-n74m5ucs	46	9	,	,	,
cord-345304-n74m5ucs	46	10	given	give	VBN
cord-345304-n74m5ucs	46	11	the	the	DT
cord-345304-n74m5ucs	46	12	lack	lack	NN
cord-345304-n74m5ucs	46	13	of	of	IN
cord-345304-n74m5ucs	46	14	evidence	evidence	NN
cord-345304-n74m5ucs	46	15	supporting	support	VBG
cord-345304-n74m5ucs	46	16	safety	safety	NN
cord-345304-n74m5ucs	46	17	and	and	CC
cord-345304-n74m5ucs	46	18	efficacy	efficacy	NN
cord-345304-n74m5ucs	46	19	of	of	IN
cord-345304-n74m5ucs	46	20	the	the	DT
cord-345304-n74m5ucs	46	21	current	current	JJ
cord-345304-n74m5ucs	46	22	available	available	JJ
cord-345304-n74m5ucs	46	23	drugs	drug	NNS
cord-345304-n74m5ucs	46	24	for	for	IN
cord-345304-n74m5ucs	46	25	the	the	DT
cord-345304-n74m5ucs	46	26	treatment	treatment	NN
cord-345304-n74m5ucs	46	27	of	of	IN
cord-345304-n74m5ucs	46	28	COVID-19	covid-19	CD
cord-345304-n74m5ucs	46	29	in	in	IN
cord-345304-n74m5ucs	46	30	children	child	NNS
cord-345304-n74m5ucs	46	31	and	and	CC
cord-345304-n74m5ucs	46	32	adolescents	adolescent	NNS
cord-345304-n74m5ucs	46	33	,	,	,
cord-345304-n74m5ucs	46	34	only	only	RB
cord-345304-n74m5ucs	46	35	supportive	supportive	JJ
cord-345304-n74m5ucs	46	36	care	care	NN
cord-345304-n74m5ucs	46	37	should	should	MD
cord-345304-n74m5ucs	46	38	be	be	VB
cord-345304-n74m5ucs	46	39	routinely	routinely	RB
cord-345304-n74m5ucs	46	40	recommended	recommend	VBN
cord-345304-n74m5ucs	46	41	for	for	IN
cord-345304-n74m5ucs	46	42	the	the	DT
cord-345304-n74m5ucs	46	43	majority	majority	NN
cord-345304-n74m5ucs	46	44	of	of	IN
cord-345304-n74m5ucs	46	45	cases	case	NNS
cord-345304-n74m5ucs	46	46	.	.	.
cord-345304-n74m5ucs	47	1	In	in	IN
cord-345304-n74m5ucs	47	2	selected	select	VBN
cord-345304-n74m5ucs	47	3	cases	case	NNS
cord-345304-n74m5ucs	47	4	,	,	,
cord-345304-n74m5ucs	47	5	of	of	IN
cord-345304-n74m5ucs	47	6	severe	severe	JJ
cord-345304-n74m5ucs	47	7	disease	disease	NN
cord-345304-n74m5ucs	47	8	presentations	presentation	NNS
cord-345304-n74m5ucs	47	9	or	or	CC
cord-345304-n74m5ucs	47	10	potential	potential	JJ
cord-345304-n74m5ucs	47	11	risk	risk	NN
cord-345304-n74m5ucs	47	12	for	for	IN
cord-345304-n74m5ucs	47	13	disease	disease	NN
cord-345304-n74m5ucs	47	14	progression	progression	NN
cord-345304-n74m5ucs	47	15	due	due	IN
cord-345304-n74m5ucs	47	16	to	to	IN
cord-345304-n74m5ucs	47	17	the	the	DT
cord-345304-n74m5ucs	47	18	presence	presence	NN
cord-345304-n74m5ucs	47	19	of	of	IN
cord-345304-n74m5ucs	47	20	strong	strong	JJ
cord-345304-n74m5ucs	47	21	risk	risk	NN
cord-345304-n74m5ucs	47	22	factors	factor	NNS
cord-345304-n74m5ucs	47	23	,	,	,
cord-345304-n74m5ucs	47	24	the	the	DT
cord-345304-n74m5ucs	47	25	use	use	NN
cord-345304-n74m5ucs	47	26	of	of	IN
cord-345304-n74m5ucs	47	27	antiviral	antiviral	JJ
cord-345304-n74m5ucs	47	28	therapy	therapy	NN
cord-345304-n74m5ucs	47	29	might	may	MD
cord-345304-n74m5ucs	47	30	be	be	VB
cord-345304-n74m5ucs	47	31	considered	consider	VBN
cord-345304-n74m5ucs	47	32	on	on	IN
cord-345304-n74m5ucs	47	33	a	a	DT
cord-345304-n74m5ucs	47	34	case	case	NN
cord-345304-n74m5ucs	47	35	-	-	HYPH
cord-345304-n74m5ucs	47	36	by	by	IN
cord-345304-n74m5ucs	47	37	-	-	HYPH
cord-345304-n74m5ucs	47	38	case	case	NN
cord-345304-n74m5ucs	47	39	individualized	individualized	JJ
cord-345304-n74m5ucs	47	40	decision	decision	NN
cord-345304-n74m5ucs	47	41	,	,	,
cord-345304-n74m5ucs	47	42	assuming	assume	VBG
cord-345304-n74m5ucs	47	43	that	that	IN
cord-345304-n74m5ucs	47	44	the	the	DT
cord-345304-n74m5ucs	47	45	benefits	benefit	NNS
cord-345304-n74m5ucs	47	46	outweigh	outweigh	VBP
cord-345304-n74m5ucs	47	47	risks	risk	NNS
cord-345304-n74m5ucs	47	48	of	of	IN
cord-345304-n74m5ucs	47	49	potential	potential	JJ
cord-345304-n74m5ucs	47	50	adverse	adverse	JJ
cord-345304-n74m5ucs	47	51	events	event	NNS
cord-345304-n74m5ucs	47	52	of	of	IN
cord-345304-n74m5ucs	47	53	the	the	DT
cord-345304-n74m5ucs	47	54	drug	drug	NN
cord-345304-n74m5ucs	47	55	used	use	VBN
cord-345304-n74m5ucs	47	56	.	.	.
cord-345304-n74m5ucs	48	1	It	-PRON-	PRP
cord-345304-n74m5ucs	48	2	is	be	VBZ
cord-345304-n74m5ucs	48	3	recommended	recommend	VBN
cord-345304-n74m5ucs	48	4	that	that	IN
cord-345304-n74m5ucs	48	5	,	,	,
cord-345304-n74m5ucs	48	6	ideally	ideally	RB
cord-345304-n74m5ucs	48	7	,	,	,
cord-345304-n74m5ucs	48	8	these	these	DT
cord-345304-n74m5ucs	48	9	off	off	IN
cord-345304-n74m5ucs	48	10	-	-	HYPH
cord-345304-n74m5ucs	48	11	label	label	NN
cord-345304-n74m5ucs	48	12	antiviral	antiviral	JJ
cord-345304-n74m5ucs	48	13	therapies	therapy	NNS
cord-345304-n74m5ucs	48	14	for	for	IN
cord-345304-n74m5ucs	48	15	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	48	16	should	should	MD
cord-345304-n74m5ucs	48	17	occur	occur	VB
cord-345304-n74m5ucs	48	18	as	as	IN
cord-345304-n74m5ucs	48	19	part	part	NN
cord-345304-n74m5ucs	48	20	of	of	IN
cord-345304-n74m5ucs	48	21	a	a	DT
cord-345304-n74m5ucs	48	22	clinical	clinical	JJ
cord-345304-n74m5ucs	48	23	trial	trial	NN
cord-345304-n74m5ucs	48	24	.	.	.
cord-345304-n74m5ucs	49	1	Post	post	JJ
cord-345304-n74m5ucs	49	2	-	-	JJ
cord-345304-n74m5ucs	49	3	exposure	exposure	JJ
cord-345304-n74m5ucs	49	4	prophylaxis	prophylaxis	NN
cord-345304-n74m5ucs	49	5	is	be	VBZ
cord-345304-n74m5ucs	49	6	another	another	DT
cord-345304-n74m5ucs	49	7	potential	potential	JJ
cord-345304-n74m5ucs	49	8	strategy	strategy	NN
cord-345304-n74m5ucs	49	9	for	for	IN
cord-345304-n74m5ucs	49	10	using	use	VBG
cord-345304-n74m5ucs	49	11	antiviral	antiviral	JJ
cord-345304-n74m5ucs	49	12	therapies	therapy	NNS
cord-345304-n74m5ucs	49	13	.	.	.
cord-345304-n74m5ucs	50	1	In	in	IN
cord-345304-n74m5ucs	50	2	this	this	DT
cord-345304-n74m5ucs	50	3	context	context	NN
cord-345304-n74m5ucs	50	4	,	,	,
cord-345304-n74m5ucs	50	5	a	a	DT
cord-345304-n74m5ucs	50	6	recent	recent	JJ
cord-345304-n74m5ucs	50	7	double	double	JJ
cord-345304-n74m5ucs	50	8	-	-	HYPH
cord-345304-n74m5ucs	50	9	blind	blind	JJ
cord-345304-n74m5ucs	50	10	randomized	randomized	JJ
cord-345304-n74m5ucs	50	11	trial	trial	NN
cord-345304-n74m5ucs	50	12	tested	test	VBD
cord-345304-n74m5ucs	50	13	the	the	DT
cord-345304-n74m5ucs	50	14	use	use	NN
cord-345304-n74m5ucs	50	15	of	of	IN
cord-345304-n74m5ucs	50	16	hydroxychloroquine	hydroxychloroquine	NN
cord-345304-n74m5ucs	50	17	within	within	IN
cord-345304-n74m5ucs	50	18	four	four	CD
cord-345304-n74m5ucs	50	19	days	day	NNS
cord-345304-n74m5ucs	50	20	after	after	IN
cord-345304-n74m5ucs	50	21	the	the	DT
cord-345304-n74m5ucs	50	22	reported	report	VBN
cord-345304-n74m5ucs	50	23	exposure	exposure	NN
cord-345304-n74m5ucs	50	24	.	.	.
cord-345304-n74m5ucs	51	1	However	however	RB
cord-345304-n74m5ucs	51	2	,	,	,
cord-345304-n74m5ucs	51	3	results	result	NNS
cord-345304-n74m5ucs	51	4	did	do	VBD
cord-345304-n74m5ucs	51	5	not	not	RB
cord-345304-n74m5ucs	51	6	show	show	VB
cord-345304-n74m5ucs	51	7	any	any	DT
cord-345304-n74m5ucs	51	8	effect	effect	NN
cord-345304-n74m5ucs	51	9	of	of	IN
cord-345304-n74m5ucs	51	10	this	this	DT
cord-345304-n74m5ucs	51	11	drug	drug	NN
cord-345304-n74m5ucs	51	12	on	on	IN
cord-345304-n74m5ucs	51	13	the	the	DT
cord-345304-n74m5ucs	51	14	prevention	prevention	NN
cord-345304-n74m5ucs	51	15	of	of	IN
cord-345304-n74m5ucs	51	16	illness	illness	NN
cord-345304-n74m5ucs	51	17	compatible	compatible	JJ
cord-345304-n74m5ucs	51	18	with	with	IN
cord-345304-n74m5ucs	51	19	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	51	20	or	or	CC
cord-345304-n74m5ucs	51	21	confirmed	confirm	VBD
cord-345304-n74m5ucs	51	22	SARS	SARS	NNP
cord-345304-n74m5ucs	51	23	-	-	HYPH
cord-345304-n74m5ucs	51	24	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	51	25	infection	infection	NN
cord-345304-n74m5ucs	51	26	when	when	WRB
cord-345304-n74m5ucs	51	27	used	use	VBN
cord-345304-n74m5ucs	51	28	as	as	IN
cord-345304-n74m5ucs	51	29	post	post	JJ
cord-345304-n74m5ucs	51	30	-	-	JJ
cord-345304-n74m5ucs	51	31	exposure	exposure	JJ
cord-345304-n74m5ucs	51	32	prophylaxis	prophylaxis	NN
cord-345304-n74m5ucs	51	33	.	.	.
cord-345304-n74m5ucs	52	1	16	16	CD
cord-345304-n74m5ucs	53	1	The	the	DT
cord-345304-n74m5ucs	53	2	most	most	RBS
cord-345304-n74m5ucs	53	3	exciting	exciting	JJ
cord-345304-n74m5ucs	53	4	and	and	CC
cord-345304-n74m5ucs	53	5	fascinating	fascinating	JJ
cord-345304-n74m5ucs	53	6	chapter	chapter	NN
cord-345304-n74m5ucs	53	7	of	of	IN
cord-345304-n74m5ucs	53	8	the	the	DT
cord-345304-n74m5ucs	53	9	battle	battle	NN
cord-345304-n74m5ucs	53	10	against	against	IN
cord-345304-n74m5ucs	53	11	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	53	12	is	be	VBZ
cord-345304-n74m5ucs	53	13	undoubtedly	undoubtedly	RB
cord-345304-n74m5ucs	53	14	the	the	DT
cord-345304-n74m5ucs	53	15	development	development	NN
cord-345304-n74m5ucs	53	16	of	of	IN
cord-345304-n74m5ucs	53	17	a	a	DT
cord-345304-n74m5ucs	53	18	safe	safe	JJ
cord-345304-n74m5ucs	53	19	and	and	CC
cord-345304-n74m5ucs	53	20	effective	effective	JJ
cord-345304-n74m5ucs	53	21	vaccine	vaccine	NN
cord-345304-n74m5ucs	53	22	.	.	.
cord-345304-n74m5ucs	54	1	We	-PRON-	PRP
cord-345304-n74m5ucs	54	2	currently	currently	RB
cord-345304-n74m5ucs	54	3	have	have	VBP
cord-345304-n74m5ucs	54	4	more	more	JJR
cord-345304-n74m5ucs	54	5	than	than	IN
cord-345304-n74m5ucs	54	6	130	130	CD
cord-345304-n74m5ucs	54	7	candidate	candidate	NN
cord-345304-n74m5ucs	54	8	vaccines	vaccine	NNS
cord-345304-n74m5ucs	54	9	being	be	VBG
cord-345304-n74m5ucs	54	10	developed	develop	VBN
cord-345304-n74m5ucs	54	11	,	,	,
cord-345304-n74m5ucs	54	12	at	at	RB
cord-345304-n74m5ucs	54	13	least	least	RBS
cord-345304-n74m5ucs	54	14	10	10	CD
cord-345304-n74m5ucs	54	15	of	of	IN
cord-345304-n74m5ucs	54	16	them	-PRON-	PRP
cord-345304-n74m5ucs	54	17	already	already	RB
cord-345304-n74m5ucs	54	18	being	be	VBG
cord-345304-n74m5ucs	54	19	tested	test	VBN
cord-345304-n74m5ucs	54	20	in	in	IN
cord-345304-n74m5ucs	54	21	humans	human	NNS
cord-345304-n74m5ucs	54	22	,	,	,
cord-345304-n74m5ucs	54	23	using	use	VBG
cord-345304-n74m5ucs	54	24	different	different	JJ
cord-345304-n74m5ucs	54	25	vaccine	vaccine	NN
cord-345304-n74m5ucs	54	26	platforms	platform	NNS
cord-345304-n74m5ucs	54	27	,	,	,
cord-345304-n74m5ucs	54	28	including	include	VBG
cord-345304-n74m5ucs	54	29	nucleic	nucleic	JJ
cord-345304-n74m5ucs	54	30	acid	acid	NN
cord-345304-n74m5ucs	54	31	-	-	HYPH
cord-345304-n74m5ucs	54	32	based	base	VBN
cord-345304-n74m5ucs	54	33	(	(	-LRB-
cord-345304-n74m5ucs	54	34	mRNA	mrna	NN
cord-345304-n74m5ucs	54	35	and	and	CC
cord-345304-n74m5ucs	54	36	DNA	DNA	NNP
cord-345304-n74m5ucs	54	37	)	)	-RRB-
cord-345304-n74m5ucs	54	38	,	,	,
cord-345304-n74m5ucs	54	39	vector	vector	NN
cord-345304-n74m5ucs	54	40	-	-	HYPH
cord-345304-n74m5ucs	54	41	based	base	VBN
cord-345304-n74m5ucs	54	42	,	,	,
cord-345304-n74m5ucs	54	43	and	and	CC
cord-345304-n74m5ucs	54	44	inactivated	inactivate	VBN
cord-345304-n74m5ucs	54	45	or	or	CC
cord-345304-n74m5ucs	54	46	recombinant	recombinant	JJ
cord-345304-n74m5ucs	54	47	protein	protein	NN
cord-345304-n74m5ucs	54	48	vaccines	vaccine	NNS
cord-345304-n74m5ucs	54	49	.	.	.
cord-345304-n74m5ucs	55	1	Studies	study	NNS
cord-345304-n74m5ucs	55	2	performed	perform	VBN
cord-345304-n74m5ucs	55	3	with	with	IN
cord-345304-n74m5ucs	55	4	several	several	JJ
cord-345304-n74m5ucs	55	5	vaccine	vaccine	NN
cord-345304-n74m5ucs	55	6	strategies	strategy	NNS
cord-345304-n74m5ucs	55	7	against	against	IN
cord-345304-n74m5ucs	55	8	the	the	DT
cord-345304-n74m5ucs	55	9	other	other	JJ
cord-345304-n74m5ucs	55	10	zoonotic	zoonotic	JJ
cord-345304-n74m5ucs	55	11	coronavirus	coronavirus	NN
cord-345304-n74m5ucs	55	12	,	,	,
cord-345304-n74m5ucs	55	13	SARS	SARS	NNP
cord-345304-n74m5ucs	55	14	-	-	HYPH
cord-345304-n74m5ucs	55	15	CoV	CoV	NNP
cord-345304-n74m5ucs	55	16	and	and	CC
cord-345304-n74m5ucs	55	17	MERS	MERS	NNP
cord-345304-n74m5ucs	55	18	-	-	HYPH
cord-345304-n74m5ucs	55	19	CoV	CoV	NNP
cord-345304-n74m5ucs	55	20	,	,	,
cord-345304-n74m5ucs	55	21	focused	focus	VBD
cord-345304-n74m5ucs	55	22	on	on	IN
cord-345304-n74m5ucs	55	23	the	the	DT
cord-345304-n74m5ucs	55	24	S	S	NNP
cord-345304-n74m5ucs	55	25	protein	protein	NN
cord-345304-n74m5ucs	55	26	target	target	NN
cord-345304-n74m5ucs	55	27	,	,	,
cord-345304-n74m5ucs	55	28	paved	pave	VBD
cord-345304-n74m5ucs	55	29	the	the	DT
cord-345304-n74m5ucs	55	30	way	way	NN
cord-345304-n74m5ucs	55	31	to	to	TO
cord-345304-n74m5ucs	55	32	facilitate	facilitate	VB
cord-345304-n74m5ucs	55	33	a	a	DT
cord-345304-n74m5ucs	55	34	more	more	RBR
cord-345304-n74m5ucs	55	35	rapid	rapid	JJ
cord-345304-n74m5ucs	55	36	development	development	NN
cord-345304-n74m5ucs	55	37	of	of	IN
cord-345304-n74m5ucs	55	38	the	the	DT
cord-345304-n74m5ucs	55	39	current	current	JJ
cord-345304-n74m5ucs	55	40	SARS	SARS	NNP
cord-345304-n74m5ucs	55	41	-	-	HYPH
cord-345304-n74m5ucs	55	42	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	55	43	vaccine	vaccine	NN
cord-345304-n74m5ucs	55	44	.	.	.
cord-345304-n74m5ucs	56	1	17	17	CD
cord-345304-n74m5ucs	57	1	Although	although	IN
cord-345304-n74m5ucs	57	2	significant	significant	JJ
cord-345304-n74m5ucs	57	3	progress	progress	NN
cord-345304-n74m5ucs	57	4	has	have	VBZ
cord-345304-n74m5ucs	57	5	been	be	VBN
cord-345304-n74m5ucs	57	6	made	make	VBN
cord-345304-n74m5ucs	57	7	in	in	IN
cord-345304-n74m5ucs	57	8	a	a	DT
cord-345304-n74m5ucs	57	9	very	very	RB
cord-345304-n74m5ucs	57	10	short	short	JJ
cord-345304-n74m5ucs	57	11	period	period	NN
cord-345304-n74m5ucs	57	12	of	of	IN
cord-345304-n74m5ucs	57	13	time	time	NN
cord-345304-n74m5ucs	57	14	,	,	,
cord-345304-n74m5ucs	57	15	we	-PRON-	PRP
cord-345304-n74m5ucs	57	16	still	still	RB
cord-345304-n74m5ucs	57	17	have	have	VBP
cord-345304-n74m5ucs	57	18	several	several	JJ
cord-345304-n74m5ucs	57	19	unanswered	unanswered	JJ
cord-345304-n74m5ucs	57	20	questions	question	NNS
cord-345304-n74m5ucs	57	21	and	and	CC
cord-345304-n74m5ucs	57	22	challenges	challenge	NNS
cord-345304-n74m5ucs	57	23	to	to	IN
cord-345304-n74m5ucs	57	24	the	the	DT
cord-345304-n74m5ucs	57	25	development	development	NN
cord-345304-n74m5ucs	57	26	of	of	IN
cord-345304-n74m5ucs	57	27	a	a	DT
cord-345304-n74m5ucs	57	28	vaccine	vaccine	NN
cord-345304-n74m5ucs	57	29	against	against	IN
cord-345304-n74m5ucs	57	30	SARS	SARS	NNP
cord-345304-n74m5ucs	57	31	-	-	HYPH
cord-345304-n74m5ucs	57	32	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	57	33	,	,	,
cord-345304-n74m5ucs	57	34	including	include	VBG
cord-345304-n74m5ucs	57	35	the	the	DT
cord-345304-n74m5ucs	57	36	theoretical	theoretical	JJ
cord-345304-n74m5ucs	57	37	risk	risk	NN
cord-345304-n74m5ucs	57	38	of	of	IN
cord-345304-n74m5ucs	57	39	Antibody	Antibody	NNP
cord-345304-n74m5ucs	57	40	-	-	HYPH
cord-345304-n74m5ucs	57	41	Dependent	Dependent	NNP
cord-345304-n74m5ucs	57	42	-	-	HYPH
cord-345304-n74m5ucs	57	43	Enhancement	Enhancement	NNP
cord-345304-n74m5ucs	57	44	,	,	,
cord-345304-n74m5ucs	57	45	the	the	DT
cord-345304-n74m5ucs	57	46	lack	lack	NN
cord-345304-n74m5ucs	57	47	of	of	IN
cord-345304-n74m5ucs	57	48	clear	clear	JJ
cord-345304-n74m5ucs	57	49	correlates	correlate	NNS
cord-345304-n74m5ucs	57	50	of	of	IN
cord-345304-n74m5ucs	57	51	protection	protection	NN
cord-345304-n74m5ucs	57	52	,	,	,
cord-345304-n74m5ucs	57	53	the	the	DT
cord-345304-n74m5ucs	57	54	long	long	JJ
cord-345304-n74m5ucs	57	55	-	-	HYPH
cord-345304-n74m5ucs	57	56	term	term	NN
cord-345304-n74m5ucs	57	57	persistence	persistence	NN
cord-345304-n74m5ucs	57	58	of	of	IN
cord-345304-n74m5ucs	57	59	the	the	DT
cord-345304-n74m5ucs	57	60	immune	immune	JJ
cord-345304-n74m5ucs	57	61	responses	response	NNS
cord-345304-n74m5ucs	57	62	induced	induce	VBN
cord-345304-n74m5ucs	57	63	by	by	IN
cord-345304-n74m5ucs	57	64	vaccination	vaccination	NN
cord-345304-n74m5ucs	57	65	,	,	,
cord-345304-n74m5ucs	57	66	the	the	DT
cord-345304-n74m5ucs	57	67	number	number	NN
cord-345304-n74m5ucs	57	68	of	of	IN
cord-345304-n74m5ucs	57	69	vaccine	vaccine	NN
cord-345304-n74m5ucs	57	70	doses	dose	NNS
cord-345304-n74m5ucs	57	71	required	require	VBN
cord-345304-n74m5ucs	57	72	for	for	IN
cord-345304-n74m5ucs	57	73	different	different	JJ
cord-345304-n74m5ucs	57	74	age	age	NN
cord-345304-n74m5ucs	57	75	groups	group	NNS
cord-345304-n74m5ucs	57	76	,	,	,
cord-345304-n74m5ucs	57	77	the	the	DT
cord-345304-n74m5ucs	57	78	probable	probable	JJ
cord-345304-n74m5ucs	57	79	need	need	NN
cord-345304-n74m5ucs	57	80	of	of	IN
cord-345304-n74m5ucs	57	81	adjuvants	adjuvant	NNS
cord-345304-n74m5ucs	57	82	to	to	TO
cord-345304-n74m5ucs	57	83	trigger	trigger	VB
cord-345304-n74m5ucs	57	84	TH1	th1	NN
cord-345304-n74m5ucs	57	85	response	response	NN
cord-345304-n74m5ucs	57	86	,	,	,
cord-345304-n74m5ucs	57	87	and	and	CC
cord-345304-n74m5ucs	57	88	high	high	JJ
cord-345304-n74m5ucs	57	89	neutralizing	neutralize	VBG
cord-345304-n74m5ucs	57	90	antibodies	antibody	NNS
cord-345304-n74m5ucs	57	91	to	to	TO
cord-345304-n74m5ucs	57	92	spare	spare	VB
cord-345304-n74m5ucs	57	93	antigen	antigen	NN
cord-345304-n74m5ucs	57	94	dosing	dosing	NN
cord-345304-n74m5ucs	57	95	.	.	.
cord-345304-n74m5ucs	58	1	It	-PRON-	PRP
cord-345304-n74m5ucs	58	2	is	be	VBZ
cord-345304-n74m5ucs	58	3	also	also	RB
cord-345304-n74m5ucs	58	4	difficult	difficult	JJ
cord-345304-n74m5ucs	58	5	to	to	TO
cord-345304-n74m5ucs	58	6	anticipate	anticipate	VB
cord-345304-n74m5ucs	58	7	whether	whether	IN
cord-345304-n74m5ucs	58	8	these	these	DT
cord-345304-n74m5ucs	58	9	vaccines	vaccine	NNS
cord-345304-n74m5ucs	58	10	will	will	MD
cord-345304-n74m5ucs	58	11	provide	provide	VB
cord-345304-n74m5ucs	58	12	protection	protection	NN
cord-345304-n74m5ucs	58	13	against	against	IN
cord-345304-n74m5ucs	58	14	infection	infection	NN
cord-345304-n74m5ucs	58	15	(	(	-LRB-
cord-345304-n74m5ucs	58	16	which	which	WDT
cord-345304-n74m5ucs	58	17	would	would	MD
cord-345304-n74m5ucs	58	18	also	also	RB
cord-345304-n74m5ucs	58	19	have	have	VB
cord-345304-n74m5ucs	58	20	the	the	DT
cord-345304-n74m5ucs	58	21	possibility	possibility	NN
cord-345304-n74m5ucs	58	22	to	to	TO
cord-345304-n74m5ucs	58	23	decrease	decrease	VB
cord-345304-n74m5ucs	58	24	transmission	transmission	NN
cord-345304-n74m5ucs	58	25	in	in	IN
cord-345304-n74m5ucs	58	26	the	the	DT
cord-345304-n74m5ucs	58	27	community	community	NN
cord-345304-n74m5ucs	58	28	once	once	IN
cord-345304-n74m5ucs	58	29	high	high	JJ
cord-345304-n74m5ucs	58	30	coverage	coverage	NN
cord-345304-n74m5ucs	58	31	is	be	VBZ
cord-345304-n74m5ucs	58	32	achieved	achieve	VBN
cord-345304-n74m5ucs	58	33	)	)	-RRB-
cord-345304-n74m5ucs	58	34	or	or	CC
cord-345304-n74m5ucs	58	35	only	only	RB
cord-345304-n74m5ucs	58	36	prevent	prevent	VB
cord-345304-n74m5ucs	58	37	disease	disease	NN
cord-345304-n74m5ucs	58	38	severity	severity	NN
cord-345304-n74m5ucs	58	39	and/or	and/or	CC
cord-345304-n74m5ucs	58	40	death	death	NN
cord-345304-n74m5ucs	58	41	.	.	.
cord-345304-n74m5ucs	59	1	17	17	CD
cord-345304-n74m5ucs	60	1	The	the	DT
cord-345304-n74m5ucs	60	2	role	role	NN
cord-345304-n74m5ucs	60	3	of	of	IN
cord-345304-n74m5ucs	60	4	a	a	DT
cord-345304-n74m5ucs	60	5	recent	recent	JJ
cord-345304-n74m5ucs	60	6	Bacille	Bacille	NNP
cord-345304-n74m5ucs	60	7	-	-	HYPH
cord-345304-n74m5ucs	60	8	Calmette	Calmette	NNP
cord-345304-n74m5ucs	60	9	-	-	HYPH
cord-345304-n74m5ucs	60	10	Guerin	Guerin	NNP
cord-345304-n74m5ucs	60	11	(	(	-LRB-
cord-345304-n74m5ucs	60	12	BCG	BCG	NNP
cord-345304-n74m5ucs	60	13	)	)	-RRB-
cord-345304-n74m5ucs	60	14	immunization	immunization	NN
cord-345304-n74m5ucs	60	15	in	in	IN
cord-345304-n74m5ucs	60	16	the	the	DT
cord-345304-n74m5ucs	60	17	prevention	prevention	NN
cord-345304-n74m5ucs	60	18	of	of	IN
cord-345304-n74m5ucs	60	19	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	60	20	is	be	VBZ
cord-345304-n74m5ucs	60	21	also	also	RB
cord-345304-n74m5ucs	60	22	being	be	VBG
cord-345304-n74m5ucs	60	23	investigated	investigate	VBN
cord-345304-n74m5ucs	60	24	in	in	IN
cord-345304-n74m5ucs	60	25	clinical	clinical	JJ
cord-345304-n74m5ucs	60	26	trials	trial	NNS
cord-345304-n74m5ucs	60	27	.	.	.
cord-345304-n74m5ucs	61	1	Previous	previous	JJ
cord-345304-n74m5ucs	61	2	studies	study	NNS
cord-345304-n74m5ucs	61	3	have	have	VBP
cord-345304-n74m5ucs	61	4	shown	show	VBN
cord-345304-n74m5ucs	61	5	that	that	IN
cord-345304-n74m5ucs	61	6	BCG	BCG	NNP
cord-345304-n74m5ucs	61	7	immunization	immunization	NN
cord-345304-n74m5ucs	61	8	,	,	,
cord-345304-n74m5ucs	61	9	besides	besides	IN
cord-345304-n74m5ucs	61	10	its	-PRON-	PRP$
cord-345304-n74m5ucs	61	11	specific	specific	JJ
cord-345304-n74m5ucs	61	12	effect	effect	NN
cord-345304-n74m5ucs	61	13	against	against	IN
cord-345304-n74m5ucs	61	14	severe	severe	JJ
cord-345304-n74m5ucs	61	15	forms	form	NNS
cord-345304-n74m5ucs	61	16	of	of	IN
cord-345304-n74m5ucs	61	17	tuberculosis	tuberculosis	NN
cord-345304-n74m5ucs	61	18	,	,	,
cord-345304-n74m5ucs	61	19	induces	induce	VBZ
cord-345304-n74m5ucs	61	20	a	a	DT
cord-345304-n74m5ucs	61	21	nonspecific	nonspecific	JJ
cord-345304-n74m5ucs	61	22	protective	protective	JJ
cord-345304-n74m5ucs	61	23	immune	immune	JJ
cord-345304-n74m5ucs	61	24	response	response	NN
cord-345304-n74m5ucs	61	25	against	against	IN
cord-345304-n74m5ucs	61	26	other	other	JJ
cord-345304-n74m5ucs	61	27	infections	infection	NNS
cord-345304-n74m5ucs	61	28	.	.	.
cord-345304-n74m5ucs	62	1	17	17	CD
cord-345304-n74m5ucs	63	1	In	in	IN
cord-345304-n74m5ucs	63	2	conclusion	conclusion	NN
cord-345304-n74m5ucs	63	3	,	,	,
cord-345304-n74m5ucs	63	4	almost	almost	RB
cord-345304-n74m5ucs	63	5	six	six	CD
cord-345304-n74m5ucs	63	6	months	month	NNS
cord-345304-n74m5ucs	63	7	into	into	IN
cord-345304-n74m5ucs	63	8	the	the	DT
cord-345304-n74m5ucs	63	9	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	63	10	pandemic	pandemic	NN
cord-345304-n74m5ucs	63	11	,	,	,
cord-345304-n74m5ucs	63	12	its	-PRON-	PRP$
cord-345304-n74m5ucs	63	13	epicenter	epicenter	NN
cord-345304-n74m5ucs	63	14	has	have	VBZ
cord-345304-n74m5ucs	63	15	displaced	displace	VBN
cord-345304-n74m5ucs	63	16	from	from	IN
cord-345304-n74m5ucs	63	17	China	China	NNP
cord-345304-n74m5ucs	63	18	,	,	,
cord-345304-n74m5ucs	63	19	Europe	Europe	NNP
cord-345304-n74m5ucs	63	20	and	and	CC
cord-345304-n74m5ucs	63	21	USA	USA	NNP
cord-345304-n74m5ucs	63	22	to	to	IN
cord-345304-n74m5ucs	63	23	Brazil	Brazil	NNP
cord-345304-n74m5ucs	63	24	,	,	,
cord-345304-n74m5ucs	63	25	exposing	expose	VBG
cord-345304-n74m5ucs	63	26	our	-PRON-	PRP$
cord-345304-n74m5ucs	63	27	vulnerable	vulnerable	JJ
cord-345304-n74m5ucs	63	28	population	population	NN
cord-345304-n74m5ucs	63	29	to	to	IN
cord-345304-n74m5ucs	63	30	devastating	devastating	JJ
cord-345304-n74m5ucs	63	31	consequences	consequence	NNS
cord-345304-n74m5ucs	63	32	.	.	.
cord-345304-n74m5ucs	64	1	Despite	despite	IN
cord-345304-n74m5ucs	64	2	the	the	DT
cord-345304-n74m5ucs	64	3	fact	fact	NN
cord-345304-n74m5ucs	64	4	that	that	IN
cord-345304-n74m5ucs	64	5	children	child	NNS
cord-345304-n74m5ucs	64	6	and	and	CC
cord-345304-n74m5ucs	64	7	adolescents	adolescent	NNS
cord-345304-n74m5ucs	64	8	appear	appear	VBP
cord-345304-n74m5ucs	64	9	to	to	TO
cord-345304-n74m5ucs	64	10	have	have	VB
cord-345304-n74m5ucs	64	11	lower	low	JJR
cord-345304-n74m5ucs	64	12	prevalence	prevalence	NN
cord-345304-n74m5ucs	64	13	,	,	,
cord-345304-n74m5ucs	64	14	milder	mild	JJR
cord-345304-n74m5ucs	64	15	clinical	clinical	JJ
cord-345304-n74m5ucs	64	16	manifestations	manifestation	NNS
cord-345304-n74m5ucs	64	17	and	and	CC
cord-345304-n74m5ucs	64	18	lower	low	JJR
cord-345304-n74m5ucs	64	19	fatality	fatality	NN
cord-345304-n74m5ucs	64	20	rates	rate	NNS
cord-345304-n74m5ucs	64	21	,	,	,
cord-345304-n74m5ucs	64	22	compared	compare	VBN
cord-345304-n74m5ucs	64	23	to	to	IN
cord-345304-n74m5ucs	64	24	other	other	JJ
cord-345304-n74m5ucs	64	25	age	age	NN
cord-345304-n74m5ucs	64	26	groups	group	NNS
cord-345304-n74m5ucs	64	27	,	,	,
cord-345304-n74m5ucs	64	28	COVID-19	covid-19	JJ
cord-345304-n74m5ucs	64	29	global	global	JJ
cord-345304-n74m5ucs	64	30	crisis	crisis	NN
cord-345304-n74m5ucs	64	31	has	have	VBZ
cord-345304-n74m5ucs	64	32	a	a	DT
cord-345304-n74m5ucs	64	33	potentially	potentially	RB
cord-345304-n74m5ucs	64	34	profound	profound	JJ
cord-345304-n74m5ucs	64	35	,	,	,
cord-345304-n74m5ucs	64	36	long	long	JJ
cord-345304-n74m5ucs	64	37	-	-	HYPH
cord-345304-n74m5ucs	64	38	term	term	NN
cord-345304-n74m5ucs	64	39	negative	negative	JJ
cord-345304-n74m5ucs	64	40	impact	impact	NN
cord-345304-n74m5ucs	64	41	on	on	IN
cord-345304-n74m5ucs	64	42	pediatric	pediatric	JJ
cord-345304-n74m5ucs	64	43	populations	population	NNS
cord-345304-n74m5ucs	64	44	.	.	.
cord-345304-n74m5ucs	65	1	The	the	DT
cord-345304-n74m5ucs	65	2	recent	recent	JJ
cord-345304-n74m5ucs	65	3	identification	identification	NN
cord-345304-n74m5ucs	65	4	of	of	IN
cord-345304-n74m5ucs	65	5	rare	rare	JJ
cord-345304-n74m5ucs	65	6	and	and	CC
cord-345304-n74m5ucs	65	7	severe	severe	JJ
cord-345304-n74m5ucs	65	8	inflammatory	inflammatory	JJ
cord-345304-n74m5ucs	65	9	syndrome	syndrome	NN
cord-345304-n74m5ucs	65	10	cases	case	NNS
cord-345304-n74m5ucs	65	11	of	of	IN
cord-345304-n74m5ucs	65	12	COVID-19	covid-19	CD
cord-345304-n74m5ucs	65	13	in	in	IN
cord-345304-n74m5ucs	65	14	older	old	JJR
cord-345304-n74m5ucs	65	15	children	child	NNS
cord-345304-n74m5ucs	65	16	and	and	CC
cord-345304-n74m5ucs	65	17	adolescents	adolescent	NNS
cord-345304-n74m5ucs	65	18	highlights	highlight	VBZ
cord-345304-n74m5ucs	65	19	its	-PRON-	PRP$
cord-345304-n74m5ucs	65	20	unpredictable	unpredictable	JJ
cord-345304-n74m5ucs	65	21	pathogenesis	pathogenesis	NN
cord-345304-n74m5ucs	65	22	spectrum	spectrum	NN
cord-345304-n74m5ucs	65	23	and	and	CC
cord-345304-n74m5ucs	65	24	outcomes	outcome	NNS
cord-345304-n74m5ucs	65	25	.	.	.
cord-345304-n74m5ucs	66	1	Mental	mental	JJ
cord-345304-n74m5ucs	66	2	health	health	NN
cord-345304-n74m5ucs	66	3	burden	burden	NN
cord-345304-n74m5ucs	66	4	,	,	,
cord-345304-n74m5ucs	66	5	social	social	JJ
cord-345304-n74m5ucs	66	6	impact	impact	NN
cord-345304-n74m5ucs	66	7	and	and	CC
cord-345304-n74m5ucs	66	8	financial	financial	JJ
cord-345304-n74m5ucs	66	9	loss	loss	NN
cord-345304-n74m5ucs	66	10	are	be	VBP
cord-345304-n74m5ucs	66	11	important	important	JJ
cord-345304-n74m5ucs	66	12	challenges	challenge	NNS
cord-345304-n74m5ucs	66	13	for	for	IN
cord-345304-n74m5ucs	66	14	children	child	NNS
cord-345304-n74m5ucs	66	15	and	and	CC
cord-345304-n74m5ucs	66	16	adolescents	adolescent	NNS
cord-345304-n74m5ucs	66	17	of	of	IN
cord-345304-n74m5ucs	66	18	this	this	DT
cord-345304-n74m5ucs	66	19	and	and	CC
cord-345304-n74m5ucs	66	20	future	future	JJ
cord-345304-n74m5ucs	66	21	generations	generation	NNS
cord-345304-n74m5ucs	66	22	.	.	.
cord-345304-n74m5ucs	67	1	Further	further	JJ
cord-345304-n74m5ucs	67	2	multicenter	multicenter	JJ
cord-345304-n74m5ucs	67	3	and	and	CC
cord-345304-n74m5ucs	67	4	longitudinal	longitudinal	JJ
cord-345304-n74m5ucs	67	5	pediatrics	pediatric	NNS
cord-345304-n74m5ucs	67	6	studies	study	NNS
cord-345304-n74m5ucs	67	7	with	with	IN
cord-345304-n74m5ucs	67	8	large	large	JJ
cord-345304-n74m5ucs	67	9	populations	population	NNS
cord-345304-n74m5ucs	67	10	will	will	MD
cord-345304-n74m5ucs	67	11	be	be	VB
cord-345304-n74m5ucs	67	12	necessary	necessary	JJ
cord-345304-n74m5ucs	67	13	to	to	TO
cord-345304-n74m5ucs	67	14	clarify	clarify	VB
cord-345304-n74m5ucs	67	15	these	these	DT
cord-345304-n74m5ucs	67	16	findings	finding	NNS
cord-345304-n74m5ucs	67	17	and	and	CC
cord-345304-n74m5ucs	67	18	to	to	TO
cord-345304-n74m5ucs	67	19	evaluate	evaluate	VB
cord-345304-n74m5ucs	67	20	specific	specific	JJ
cord-345304-n74m5ucs	67	21	healthy	healthy	JJ
cord-345304-n74m5ucs	67	22	and	and	CC
cord-345304-n74m5ucs	67	23	preexisting	preexisting	JJ
cord-345304-n74m5ucs	67	24	chronic	chronic	JJ
cord-345304-n74m5ucs	67	25	diseases	disease	NNS
cord-345304-n74m5ucs	67	26	in	in	IN
cord-345304-n74m5ucs	67	27	children	child	NNS
cord-345304-n74m5ucs	67	28	and	and	CC
cord-345304-n74m5ucs	67	29	adolescents	adolescent	NNS
cord-345304-n74m5ucs	67	30	.	.	.
cord-345304-n74m5ucs	68	1	Coronavirus	Coronavirus	NNP
cord-345304-n74m5ucs	68	2	disease	disease	NN
cord-345304-n74m5ucs	68	3	(	(	-LRB-
cord-345304-n74m5ucs	68	4	COVID-19	covid-19	VB
cord-345304-n74m5ucs	68	5	)	)	-RRB-
cord-345304-n74m5ucs	68	6	pandemic	pandemic	NN
cord-345304-n74m5ucs	68	7	.	.	.
cord-345304-n74m5ucs	69	1	Geneva	Geneva	NNP
cord-345304-n74m5ucs	69	2	:	:	:
cord-345304-n74m5ucs	69	3	WHO	who	WP
cord-345304-n74m5ucs	69	4	;	;	:
cord-345304-n74m5ucs	70	1	2020	2020	CD
cord-345304-n74m5ucs	71	1	The	the	DT
cord-345304-n74m5ucs	71	2	intriguing	intriguing	JJ
cord-345304-n74m5ucs	71	3	features	feature	NNS
cord-345304-n74m5ucs	71	4	of	of	IN
cord-345304-n74m5ucs	71	5	COVID-19	covid-19	CD
cord-345304-n74m5ucs	71	6	in	in	IN
cord-345304-n74m5ucs	71	7	children	child	NNS
cord-345304-n74m5ucs	71	8	and	and	CC
cord-345304-n74m5ucs	71	9	its	-PRON-	PRP$
cord-345304-n74m5ucs	71	10	impact	impact	NN
cord-345304-n74m5ucs	71	11	on	on	IN
cord-345304-n74m5ucs	71	12	the	the	DT
cord-345304-n74m5ucs	71	13	pandemic	pandemic	NN
cord-345304-n74m5ucs	72	1	Why	why	WRB
cord-345304-n74m5ucs	72	2	is	be	VBZ
cord-345304-n74m5ucs	72	3	SARS	SARS	NNP
cord-345304-n74m5ucs	72	4	-	-	HYPH
cord-345304-n74m5ucs	72	5	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	72	6	infection	infection	NN
cord-345304-n74m5ucs	72	7	milder	mild	JJR
cord-345304-n74m5ucs	72	8	among	among	IN
cord-345304-n74m5ucs	72	9	children	child	NNS
cord-345304-n74m5ucs	72	10	?	?	.
cord-345304-n74m5ucs	73	1	Hematuria	Hematuria	NNP
cord-345304-n74m5ucs	73	2	associated	associate	VBN
cord-345304-n74m5ucs	73	3	with	with	IN
cord-345304-n74m5ucs	73	4	SARS	SARS	NNP
cord-345304-n74m5ucs	73	5	-	-	HYPH
cord-345304-n74m5ucs	73	6	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	73	7	infection	infection	NN
cord-345304-n74m5ucs	73	8	in	in	IN
cord-345304-n74m5ucs	73	9	a	a	DT
cord-345304-n74m5ucs	73	10	child	child	NN
cord-345304-n74m5ucs	73	11	COVID-19	covid-19	CD
cord-345304-n74m5ucs	73	12	transmission	transmission	NN
cord-345304-n74m5ucs	73	13	and	and	CC
cord-345304-n74m5ucs	73	14	children	child	NNS
cord-345304-n74m5ucs	73	15	:	:	:
cord-345304-n74m5ucs	73	16	the	the	DT
cord-345304-n74m5ucs	73	17	child	child	NN
cord-345304-n74m5ucs	73	18	is	be	VBZ
cord-345304-n74m5ucs	73	19	not	not	RB
cord-345304-n74m5ucs	73	20	to	to	TO
cord-345304-n74m5ucs	73	21	blame	blame	VB
cord-345304-n74m5ucs	73	22	Clinical	clinical	JJ
cord-345304-n74m5ucs	73	23	characteristics	characteristic	NNS
cord-345304-n74m5ucs	73	24	of	of	IN
cord-345304-n74m5ucs	73	25	58	58	CD
cord-345304-n74m5ucs	73	26	children	child	NNS
cord-345304-n74m5ucs	73	27	with	with	IN
cord-345304-n74m5ucs	73	28	a	a	DT
cord-345304-n74m5ucs	73	29	pediatric	pediatric	JJ
cord-345304-n74m5ucs	73	30	inflammatory	inflammatory	JJ
cord-345304-n74m5ucs	73	31	multisystem	multisystem	JJ
cord-345304-n74m5ucs	73	32	syndrome	syndrome	NN
cord-345304-n74m5ucs	73	33	temporally	temporally	RB
cord-345304-n74m5ucs	73	34	associated	associate	VBN
cord-345304-n74m5ucs	73	35	with	with	IN
cord-345304-n74m5ucs	73	36	SARS	SARS	NNP
cord-345304-n74m5ucs	73	37	-	-	HYPH
cord-345304-n74m5ucs	73	38	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	73	39	Coronavirus	Coronavirus	NNP
cord-345304-n74m5ucs	73	40	Infection	infection	NN
cord-345304-n74m5ucs	73	41	in	in	IN
cord-345304-n74m5ucs	73	42	Pediatric	Pediatric	NNP
cord-345304-n74m5ucs	73	43	Emergency	Emergency	NNP
cord-345304-n74m5ucs	73	44	Departments	Departments	NNPS
cord-345304-n74m5ucs	73	45	(	(	-LRB-
cord-345304-n74m5ucs	73	46	CONFIDENCE	CONFIDENCE	NNP
cord-345304-n74m5ucs	73	47	)	)	-RRB-
cord-345304-n74m5ucs	73	48	Research	Research	NNP
cord-345304-n74m5ucs	73	49	Group	Group	NNP
cord-345304-n74m5ucs	73	50	.	.	.
cord-345304-n74m5ucs	74	1	Children	child	NNS
cord-345304-n74m5ucs	74	2	with	with	IN
cord-345304-n74m5ucs	74	3	Covid-19	covid-19	NN
cord-345304-n74m5ucs	74	4	in	in	IN
cord-345304-n74m5ucs	74	5	pediatric	pediatric	JJ
cord-345304-n74m5ucs	74	6	emergency	emergency	NN
cord-345304-n74m5ucs	74	7	departments	department	NNS
cord-345304-n74m5ucs	74	8	in	in	IN
cord-345304-n74m5ucs	74	9	Italy	Italy	NNP
cord-345304-n74m5ucs	74	10	Response	Response	NNP
cord-345304-n74m5ucs	74	11	Team	Team	NNP
cord-345304-n74m5ucs	74	12	.	.	.
cord-345304-n74m5ucs	75	1	Coronavirus	Coronavirus	NNP
cord-345304-n74m5ucs	75	2	disease	disease	NN
cord-345304-n74m5ucs	75	3	2019	2019	CD
cord-345304-n74m5ucs	75	4	in	in	IN
cord-345304-n74m5ucs	75	5	children	child	NNS
cord-345304-n74m5ucs	76	1	-United	-United	NNP
cord-345304-n74m5ucs	76	2	States	States	NNP
cord-345304-n74m5ucs	76	3	Characteristics	characteristic	NNS
cord-345304-n74m5ucs	76	4	and	and	CC
cord-345304-n74m5ucs	76	5	outcomes	outcome	NNS
cord-345304-n74m5ucs	76	6	of	of	IN
cord-345304-n74m5ucs	76	7	children	child	NNS
cord-345304-n74m5ucs	76	8	with	with	IN
cord-345304-n74m5ucs	76	9	coronavirus	coronavirus	NN
cord-345304-n74m5ucs	76	10	disease	disease	NN
cord-345304-n74m5ucs	76	11	2019	2019	CD
cord-345304-n74m5ucs	76	12	(	(	-LRB-
cord-345304-n74m5ucs	76	13	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	76	14	)	)	-RRB-
cord-345304-n74m5ucs	76	15	infection	infection	NN
cord-345304-n74m5ucs	76	16	admitted	admit	VBD
cord-345304-n74m5ucs	76	17	to	to	IN
cord-345304-n74m5ucs	76	18	US	US	NNP
cord-345304-n74m5ucs	76	19	and	and	CC
cord-345304-n74m5ucs	76	20	Canadian	canadian	JJ
cord-345304-n74m5ucs	76	21	pediatric	pediatric	JJ
cord-345304-n74m5ucs	76	22	intensive	intensive	JJ
cord-345304-n74m5ucs	76	23	care	care	NN
cord-345304-n74m5ucs	76	24	units	unit	NNS
cord-345304-n74m5ucs	76	25	Clinical	clinical	JJ
cord-345304-n74m5ucs	76	26	characteristics	characteristic	NNS
cord-345304-n74m5ucs	76	27	and	and	CC
cord-345304-n74m5ucs	76	28	outcomes	outcome	NNS
cord-345304-n74m5ucs	76	29	of	of	IN
cord-345304-n74m5ucs	76	30	hospitalized	hospitalize	VBN
cord-345304-n74m5ucs	76	31	and	and	CC
cord-345304-n74m5ucs	76	32	critically	critically	RB
cord-345304-n74m5ucs	76	33	Ill	ill	JJ
cord-345304-n74m5ucs	76	34	children	child	NNS
cord-345304-n74m5ucs	76	35	and	and	CC
cord-345304-n74m5ucs	76	36	adolescents	adolescent	NNS
cord-345304-n74m5ucs	76	37	with	with	IN
cord-345304-n74m5ucs	76	38	coronavirus	coronavirus	NN
cord-345304-n74m5ucs	76	39	disease	disease	NN
cord-345304-n74m5ucs	76	40	2019	2019	CD
cord-345304-n74m5ucs	77	1	(	(	-LRB-
cord-345304-n74m5ucs	77	2	COVID-19	covid-19	VB
cord-345304-n74m5ucs	77	3	)	)	-RRB-
cord-345304-n74m5ucs	77	4	at	at	IN
cord-345304-n74m5ucs	77	5	a	a	DT
cord-345304-n74m5ucs	77	6	tertiary	tertiary	JJ
cord-345304-n74m5ucs	77	7	care	care	NN
cord-345304-n74m5ucs	77	8	medical	medical	JJ
cord-345304-n74m5ucs	77	9	center	center	NN
cord-345304-n74m5ucs	77	10	in	in	IN
cord-345304-n74m5ucs	77	11	New	New	NNP
cord-345304-n74m5ucs	77	12	York	York	NNP
cord-345304-n74m5ucs	77	13	City	City	NNP
cord-345304-n74m5ucs	77	14	Spotlight	Spotlight	NNP
cord-345304-n74m5ucs	77	15	for	for	IN
cord-345304-n74m5ucs	77	16	healthy	healthy	JJ
cord-345304-n74m5ucs	77	17	and	and	CC
cord-345304-n74m5ucs	77	18	preexisting	preexisting	JJ
cord-345304-n74m5ucs	77	19	chronic	chronic	JJ
cord-345304-n74m5ucs	77	20	diseases	disease	NNS
cord-345304-n74m5ucs	77	21	adolescents	adolescent	NNS
cord-345304-n74m5ucs	77	22	during	during	IN
cord-345304-n74m5ucs	77	23	COVID-19	covid-19	CD
cord-345304-n74m5ucs	77	24	pandemic	pandemic	NN
cord-345304-n74m5ucs	77	25	Low	low	JJ
cord-345304-n74m5ucs	77	26	incidence	incidence	NN
cord-345304-n74m5ucs	77	27	of	of	IN
cord-345304-n74m5ucs	77	28	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	77	29	in	in	IN
cord-345304-n74m5ucs	77	30	children	child	NNS
cord-345304-n74m5ucs	77	31	and	and	CC
cord-345304-n74m5ucs	77	32	adolescent	adolescent	JJ
cord-345304-n74m5ucs	77	33	post	post	JJ
cord-345304-n74m5ucs	77	34	-	-	JJ
cord-345304-n74m5ucs	77	35	liver	liver	JJ
cord-345304-n74m5ucs	77	36	transplant	transplant	NN
cord-345304-n74m5ucs	77	37	at	at	IN
cord-345304-n74m5ucs	77	38	a	a	DT
cord-345304-n74m5ucs	77	39	Latin	latin	JJ
cord-345304-n74m5ucs	77	40	American	american	JJ
cord-345304-n74m5ucs	77	41	reference	reference	NN
cord-345304-n74m5ucs	77	42	center	center	NN
cord-345304-n74m5ucs	77	43	COVID-19	COVID-19	VBD
cord-345304-n74m5ucs	77	44	in	in	IN
cord-345304-n74m5ucs	77	45	children	child	NNS
cord-345304-n74m5ucs	77	46	with	with	IN
cord-345304-n74m5ucs	77	47	cancer	cancer	NN
cord-345304-n74m5ucs	77	48	in	in	IN
cord-345304-n74m5ucs	77	49	New	New	NNP
cord-345304-n74m5ucs	77	50	York	York	NNP
cord-345304-n74m5ucs	77	51	city	city	NN
cord-345304-n74m5ucs	78	1	The	the	DT
cord-345304-n74m5ucs	78	2	psychological	psychological	JJ
cord-345304-n74m5ucs	78	3	impact	impact	NN
cord-345304-n74m5ucs	78	4	of	of	IN
cord-345304-n74m5ucs	78	5	quarantine	quarantine	NN
cord-345304-n74m5ucs	78	6	and	and	CC
cord-345304-n74m5ucs	78	7	how	how	WRB
cord-345304-n74m5ucs	78	8	to	to	TO
cord-345304-n74m5ucs	78	9	reduce	reduce	VB
cord-345304-n74m5ucs	78	10	it	-PRON-	PRP
cord-345304-n74m5ucs	78	11	:	:	:
cord-345304-n74m5ucs	78	12	rapid	rapid	JJ
cord-345304-n74m5ucs	78	13	review	review	NN
cord-345304-n74m5ucs	78	14	of	of	IN
cord-345304-n74m5ucs	78	15	the	the	DT
cord-345304-n74m5ucs	78	16	evidence	evidence	NN
cord-345304-n74m5ucs	78	17	Multicenter	multicenter	JJ
cord-345304-n74m5ucs	78	18	initial	initial	JJ
cord-345304-n74m5ucs	78	19	guidance	guidance	NN
cord-345304-n74m5ucs	78	20	on	on	IN
cord-345304-n74m5ucs	78	21	use	use	NN
cord-345304-n74m5ucs	78	22	of	of	IN
cord-345304-n74m5ucs	78	23	antivirals	antiviral	NNS
cord-345304-n74m5ucs	78	24	for	for	IN
cord-345304-n74m5ucs	78	25	children	child	NNS
cord-345304-n74m5ucs	78	26	with	with	IN
cord-345304-n74m5ucs	78	27	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	78	28	/	/	SYM
cord-345304-n74m5ucs	78	29	SARS	SARS	NNP
cord-345304-n74m5ucs	78	30	-	-	HYPH
cord-345304-n74m5ucs	78	31	CoV-2	CoV-2	NNP
cord-345304-n74m5ucs	79	1	A	a	DT
cord-345304-n74m5ucs	79	2	randomized	randomized	JJ
cord-345304-n74m5ucs	79	3	trial	trial	NN
cord-345304-n74m5ucs	79	4	of	of	IN
cord-345304-n74m5ucs	79	5	hydroxychloroquine	hydroxychloroquine	NN
cord-345304-n74m5ucs	79	6	as	as	IN
cord-345304-n74m5ucs	79	7	postexposure	postexposure	NN
cord-345304-n74m5ucs	79	8	prophylaxis	prophylaxis	NN
cord-345304-n74m5ucs	79	9	for	for	IN
cord-345304-n74m5ucs	79	10	COVID-19	COVID-19	NNP
cord-345304-n74m5ucs	79	11	The	the	DT
cord-345304-n74m5ucs	79	12	challenges	challenge	NNS
cord-345304-n74m5ucs	79	13	of	of	IN
cord-345304-n74m5ucs	79	14	vaccine	vaccine	NN
cord-345304-n74m5ucs	79	15	development	development	NN
cord-345304-n74m5ucs	79	16	against	against	IN
cord-345304-n74m5ucs	79	17	a	a	DT
cord-345304-n74m5ucs	79	18	new	new	JJ
cord-345304-n74m5ucs	79	19	virus	virus	NN
cord-345304-n74m5ucs	79	20	during	during	IN
cord-345304-n74m5ucs	79	21	a	a	DT
cord-345304-n74m5ucs	79	22	pandemic	pandemic	NN
cord-345304-n74m5ucs	80	1	The	the	DT
cord-345304-n74m5ucs	80	2	authors	author	NNS
cord-345304-n74m5ucs	80	3	declare	declare	VBP
cord-345304-n74m5ucs	80	4	no	no	DT
cord-345304-n74m5ucs	80	5	conflict	conflict	NN
cord-345304-n74m5ucs	80	6	of	of	IN
cord-345304-n74m5ucs	80	7	interests	interest	NNS
cord-345304-n74m5ucs	80	8	.	.	.
cord-345304-n74m5ucs	81	1	This	this	DT
cord-345304-n74m5ucs	81	2	study	study	NN
cord-345304-n74m5ucs	81	3	was	be	VBD
cord-345304-n74m5ucs	81	4	supported	support	VBN
cord-345304-n74m5ucs	81	5	by	by	IN
cord-345304-n74m5ucs	81	6	grants	grant	NNS
cord-345304-n74m5ucs	81	7	from	from	IN
cord-345304-n74m5ucs	81	8	Conselho	Conselho	NNP
cord-345304-n74m5ucs	81	9	Nacional	Nacional	NNP
cord-345304-n74m5ucs	81	10	de	de	NNP
cord-345304-n74m5ucs	81	11	Desenvolvimento	Desenvolvimento	NNP
cord-345304-n74m5ucs	81	12	Científico	Científico	NNP
cord-345304-n74m5ucs	81	13	e	e	NNP
cord-345304-n74m5ucs	81	14	Tecnológico	Tecnológico	NNP
cord-345304-n74m5ucs	81	15	(	(	-LRB-
cord-345304-n74m5ucs	81	16	CNPq	CNPq	NNP
cord-345304-n74m5ucs	81	17	303422/2015	303422/2015	CD
cord-345304-n74m5ucs	81	18	-	-	SYM
cord-345304-n74m5ucs	81	19	7	7	CD
cord-345304-n74m5ucs	81	20	to	to	IN
cord-345304-n74m5ucs	81	21	CAS	CAS	NNP
cord-345304-n74m5ucs	81	22	)	)	-RRB-
cord-345304-n74m5ucs	81	23	,	,	.
cord-345304-n74m5ucs	82	1	Fundação	Fundação	NNP
cord-345304-n74m5ucs	82	2	de	de	NNP
cord-345304-n74m5ucs	82	3	Amparo	Amparo	NNP
cord-345304-n74m5ucs	82	4	à	à	FW
cord-345304-n74m5ucs	82	5	Pesquisa	Pesquisa	NNP
cord-345304-n74m5ucs	82	6	do	do	VBP
cord-345304-n74m5ucs	82	7	Estado	Estado	NNP
cord-345304-n74m5ucs	82	8	de	de	FW
cord-345304-n74m5ucs	82	9	São	São	NNP
cord-345304-n74m5ucs	82	10	Paulo	Paulo	NNP
cord-345304-n74m5ucs	82	11	(	(	-LRB-
cord-345304-n74m5ucs	82	12	FAPESP	FAPESP	NNP
cord-345304-n74m5ucs	82	13	2015/03756	2015/03756	CD
cord-345304-n74m5ucs	82	14	-	-	SYM
cord-345304-n74m5ucs	82	15	4	4	CD
cord-345304-n74m5ucs	82	16	to	to	IN
cord-345304-n74m5ucs	82	17	CAS	CAS	NNP
cord-345304-n74m5ucs	82	18	)	)	-RRB-
cord-345304-n74m5ucs	82	19	,	,	,
cord-345304-n74m5ucs	82	20	and	and	CC
cord-345304-n74m5ucs	83	1	by	by	IN
cord-345304-n74m5ucs	83	2	Núcleo	Núcleo	NNP
cord-345304-n74m5ucs	83	3	de	de	NNP
cord-345304-n74m5ucs	83	4	Apoio	Apoio	NNP
cord-345304-n74m5ucs	83	5	à	à	IN
cord-345304-n74m5ucs	83	6	Pesquisa	Pesquisa	NNP
cord-345304-n74m5ucs	83	7	"	"	``
cord-345304-n74m5ucs	83	8	Saúde	Saúde	NNP
cord-345304-n74m5ucs	83	9	da	da	NNP
cord-345304-n74m5ucs	83	10	Criança	Criança	NNP
cord-345304-n74m5ucs	83	11	e	e	NN
cord-345304-n74m5ucs	83	12	do	do	NN
cord-345304-n74m5ucs	84	1	Adolescente	Adolescente	NNP
cord-345304-n74m5ucs	84	2	"	"	``
cord-345304-n74m5ucs	84	3	da	da	NNP
cord-345304-n74m5ucs	84	4	USP	USP	NNP
cord-345304-n74m5ucs	84	5	(	(	-LRB-
cord-345304-n74m5ucs	84	6	NAP	nap	NN
cord-345304-n74m5ucs	84	7	-	-	HYPH
cord-345304-n74m5ucs	84	8	CriAd	criad	NN
cord-345304-n74m5ucs	84	9	)	)	-RRB-
cord-345304-n74m5ucs	84	10	to	to	IN
cord-345304-n74m5ucs	84	11	CAS	CAS	NNP
cord-345304-n74m5ucs	84	12	.	.	.